Datasets:

presencesw

/

mednli

like 0

23ef0276-66c7-11e7-94f9-f45c89b91419

entailment

His O2Sat remains above 90% on room air but appears to drop when patient falls asleep.

Patient has OND

(ROOT (S (NP (PRP$ His) (NN O2Sat)) (VP (VP (VBZ remains) (PP (IN above) (NP (NP (CD 90) (NN %)) (PP (IN on) (NP (NN room) (NN air)))))) (CC but) (VP (VBZ appears) (S (VP (TO to) (VP (VB drop) (SBAR (WHADVP (WRB when)) (S (NP (NN patient)) (VP (VBZ falls) (ADVP (RB asleep)))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (NN OND)))))

( ( His O2Sat ) ( ( ( ( remains ( above ( ( 90 % ) ( on ( room air ) ) ) ) ) but ) ( appears ( to ( drop ( when ( patient ( falls asleep ) ) ) ) ) ) ) . ) )

( Patient ( has OND ) )

23ef0422-66c7-11e7-9298-f45c89b91419

contradiction

His O2Sat remains above 90% on room air but appears to drop when patient falls asleep.

Patient has normal O2 sats

(ROOT (S (NP (PRP$ His) (NN O2Sat)) (VP (VP (VBZ remains) (PP (IN above) (NP (NP (CD 90) (NN %)) (PP (IN on) (NP (NN room) (NN air)))))) (CC but) (VP (VBZ appears) (S (VP (TO to) (VP (VB drop) (SBAR (WHADVP (WRB when)) (S (NP (NN patient)) (VP (VBZ falls) (ADVP (RB asleep)))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (JJ normal) (CD O2) (NNS sats)))))

( ( His O2Sat ) ( ( ( ( remains ( above ( ( 90 % ) ( on ( room air ) ) ) ) ) but ) ( appears ( to ( drop ( when ( patient ( falls asleep ) ) ) ) ) ) ) . ) )

( Patient ( has ( normal ( O2 sats ) ) ) )

23ef05c6-66c7-11e7-bf2b-f45c89b91419

neutral

His O2Sat remains above 90% on room air but appears to drop when patient falls asleep.

Patient has CHF

(ROOT (S (NP (PRP$ His) (NN O2Sat)) (VP (VP (VBZ remains) (PP (IN above) (NP (NP (CD 90) (NN %)) (PP (IN on) (NP (NN room) (NN air)))))) (CC but) (VP (VBZ appears) (S (VP (TO to) (VP (VB drop) (SBAR (WHADVP (WRB when)) (S (NP (NN patient)) (VP (VBZ falls) (ADVP (RB asleep)))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (NN CHF)))))

( ( His O2Sat ) ( ( ( ( remains ( above ( ( 90 % ) ( on ( room air ) ) ) ) ) but ) ( appears ( to ( drop ( when ( patient ( falls asleep ) ) ) ) ) ) ) . ) )

( Patient ( has CHF ) )

23ef0774-66c7-11e7-8c4c-f45c89b91419

entailment

Transferred from OSH to [**Hospital1 22**] for cath with revealed 3vd and left main disease.

The patient has three vessel disease

(ROOT (S (VP (VP (VBN Transferred) (PP (IN from) (NP (NNP OSH))) (S (VP (TO to) (VP (-LRB- -LSB-) (SYM **) (NP (NP (NN Hospital1) (CD 22)) (X (SYM **))) (VP (-RRB- -RSB-) (PP (IN for) (NP (NP (NN cath)) (PP (IN with) (NP (VBN revealed) (NN 3vd)))))))))) (CC and) (VP (VBD left) (NP (JJ main) (NN disease)))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (CD three) (NN vessel) (NN disease)))))

( ( ( ( ( Transferred ( from OSH ) ) ( to ( -LSB- ( ** ( ( ( Hospital1 22 ) ** ) ( -RSB- ( for ( cath ( with ( revealed 3vd ) ) ) ) ) ) ) ) ) ) and ) ( left ( main disease ) ) ) . )

( ( The patient ) ( has ( three ( vessel disease ) ) ) )

23ef0924-66c7-11e7-9a73-f45c89b91419

contradiction

Transferred from OSH to [**Hospital1 22**] for cath with revealed 3vd and left main disease.

The patient has no cardiac disease

(ROOT (S (VP (VP (VBN Transferred) (PP (IN from) (NP (NNP OSH))) (S (VP (TO to) (VP (-LRB- -LSB-) (SYM **) (NP (NP (NN Hospital1) (CD 22)) (X (SYM **))) (VP (-RRB- -RSB-) (PP (IN for) (NP (NP (NN cath)) (PP (IN with) (NP (VBN revealed) (NN 3vd)))))))))) (CC and) (VP (VBD left) (NP (JJ main) (NN disease)))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (DT no) (JJ cardiac) (NN disease)))))

( ( ( ( ( Transferred ( from OSH ) ) ( to ( -LSB- ( ** ( ( ( Hospital1 22 ) ** ) ( -RSB- ( for ( cath ( with ( revealed 3vd ) ) ) ) ) ) ) ) ) ) and ) ( left ( main disease ) ) ) . )

( ( The patient ) ( has ( no ( cardiac disease ) ) ) )

23ef0aee-66c7-11e7-90a9-f45c89b91419

neutral

Transferred from OSH to [**Hospital1 22**] for cath with revealed 3vd and left main disease.

The patient has a history of hypertension, hyperlipidemia and obesity

(ROOT (S (VP (VP (VBN Transferred) (PP (IN from) (NP (NNP OSH))) (S (VP (TO to) (VP (-LRB- -LSB-) (SYM **) (NP (NP (NN Hospital1) (CD 22)) (X (SYM **))) (VP (-RRB- -RSB-) (PP (IN for) (NP (NP (NN cath)) (PP (IN with) (NP (VBN revealed) (NN 3vd)))))))))) (CC and) (VP (VBD left) (NP (JJ main) (NN disease)))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NP (NN hypertension)) (, ,) (NP (NN hyperlipidemia)) (CC and) (NP (NN obesity))))))))

( ( ( ( ( Transferred ( from OSH ) ) ( to ( -LSB- ( ** ( ( ( Hospital1 22 ) ** ) ( -RSB- ( for ( cath ( with ( revealed 3vd ) ) ) ) ) ) ) ) ) ) and ) ( left ( main disease ) ) ) . )

( ( The patient ) ( has ( ( a history ) ( of ( ( ( ( hypertension , ) hyperlipidemia ) and ) obesity ) ) ) ) )

23ef0ca6-66c7-11e7-8d41-f45c89b91419

entailment

He was started empirically on zosyn for aspiration pneumonia; UA was positive for UTI with pseudomonas.

The patient has a urinary tract infection.

(ROOT (S (S (NP (PRP He)) (VP (VBD was) (VP (VBN started) (PP (ADVP (RB empirically)) (IN on) (NP (NP (NN zosyn)) (PP (IN for) (NP (NN aspiration) (NN pneumonia)))))))) (: ;) (S (NP (NNP UA)) (VP (VBD was) (ADJP (JJ positive)) (PP (IN for) (NP (NP (NN UTI)) (PP (IN with) (NP (NNS pseudomonas))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (DT a) (JJ urinary) (NN tract) (NN infection))) (. .)))

( ( ( ( He ( was ( started ( empirically ( on ( zosyn ( for ( aspiration pneumonia ) ) ) ) ) ) ) ) ; ) ( UA ( ( was positive ) ( for ( UTI ( with pseudomonas ) ) ) ) ) ) . )

( ( The patient ) ( ( has ( a ( urinary ( tract infection ) ) ) ) . ) )

23ef0f4c-66c7-11e7-bda1-f45c89b91419

contradiction

He was started empirically on zosyn for aspiration pneumonia; UA was positive for UTI with pseudomonas.

The patient has clear lungs.

(ROOT (S (S (NP (PRP He)) (VP (VBD was) (VP (VBN started) (PP (ADVP (RB empirically)) (IN on) (NP (NP (NN zosyn)) (PP (IN for) (NP (NN aspiration) (NN pneumonia)))))))) (: ;) (S (NP (NNP UA)) (VP (VBD was) (ADJP (JJ positive)) (PP (IN for) (NP (NP (NN UTI)) (PP (IN with) (NP (NNS pseudomonas))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (JJ clear) (NNS lungs))) (. .)))

( ( ( ( He ( was ( started ( empirically ( on ( zosyn ( for ( aspiration pneumonia ) ) ) ) ) ) ) ) ; ) ( UA ( ( was positive ) ( for ( UTI ( with pseudomonas ) ) ) ) ) ) . )

( ( The patient ) ( ( has ( clear lungs ) ) . ) )

23ef1412-66c7-11e7-907b-f45c89b91419

neutral

He was started empirically on zosyn for aspiration pneumonia; UA was positive for UTI with pseudomonas.

The patient has dysphagia.

(ROOT (S (S (NP (PRP He)) (VP (VBD was) (VP (VBN started) (PP (ADVP (RB empirically)) (IN on) (NP (NP (NN zosyn)) (PP (IN for) (NP (NN aspiration) (NN pneumonia)))))))) (: ;) (S (NP (NNP UA)) (VP (VBD was) (ADJP (JJ positive)) (PP (IN for) (NP (NP (NN UTI)) (PP (IN with) (NP (NNS pseudomonas))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NN dysphagia))) (. .)))

( ( ( ( He ( was ( started ( empirically ( on ( zosyn ( for ( aspiration pneumonia ) ) ) ) ) ) ) ) ; ) ( UA ( ( was positive ) ( for ( UTI ( with pseudomonas ) ) ) ) ) ) . )

( ( The patient ) ( ( has dysphagia ) . ) )

23ef1886-66c7-11e7-9df8-f45c89b91419

entailment

The tumor was ER+/HER-2-NEU positive, and she is undergoing Tamoxifen therapy.

Patient has breast cancer

(ROOT (S (S (NP (DT The) (NN tumor)) (VP (VBD was) (S (NP (NP (NN ER)) (CC +) (: /)) (ADJP (NN HER-2-NEU) (JJ positive))))) (, ,) (CC and) (S (NP (PRP she)) (VP (VBZ is) (VP (VBG undergoing) (NP (NN Tamoxifen) (NN therapy))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (NN breast) (NN cancer)))))

( ( ( ( ( ( The tumor ) ( was ( ( ( ER + ) / ) ( HER-2-NEU positive ) ) ) ) , ) and ) ( she ( is ( undergoing ( Tamoxifen therapy ) ) ) ) ) . )

( Patient ( has ( breast cancer ) ) )

23ef1ee4-66c7-11e7-912a-f45c89b91419

contradiction

The tumor was ER+/HER-2-NEU positive, and she is undergoing Tamoxifen therapy.

Patient has no history of malignancy

(ROOT (S (S (NP (DT The) (NN tumor)) (VP (VBD was) (S (NP (NP (NN ER)) (CC +) (: /)) (ADJP (NN HER-2-NEU) (JJ positive))))) (, ,) (CC and) (S (NP (PRP she)) (VP (VBZ is) (VP (VBG undergoing) (NP (NN Tamoxifen) (NN therapy))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (NP (DT no) (NN history)) (PP (IN of) (NP (NN malignancy)))))))

( ( ( ( ( ( The tumor ) ( was ( ( ( ER + ) / ) ( HER-2-NEU positive ) ) ) ) , ) and ) ( she ( is ( undergoing ( Tamoxifen therapy ) ) ) ) ) . )

( Patient ( has ( ( no history ) ( of malignancy ) ) ) )

23ef20ec-66c7-11e7-b884-f45c89b91419

neutral

The tumor was ER+/HER-2-NEU positive, and she is undergoing Tamoxifen therapy.

Patient has abnormal PET/CT

(ROOT (S (S (NP (DT The) (NN tumor)) (VP (VBD was) (S (NP (NP (NN ER)) (CC +) (: /)) (ADJP (NN HER-2-NEU) (JJ positive))))) (, ,) (CC and) (S (NP (PRP she)) (VP (VBZ is) (VP (VBG undergoing) (NP (NN Tamoxifen) (NN therapy))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (JJ abnormal) (NN PET/CT)))))

( ( ( ( ( ( The tumor ) ( was ( ( ( ER + ) / ) ( HER-2-NEU positive ) ) ) ) , ) and ) ( she ( is ( undergoing ( Tamoxifen therapy ) ) ) ) ) . )

( Patient ( has ( abnormal PET/CT ) ) )

23ef22b8-66c7-11e7-93e1-f45c89b91419

entailment

Has chronic hypertension treated with Labetalol and hypothyroidism treated with Thyroxine.

the patient has hypertension

(ROOT (S (VP (VBZ Has) (NP (NP (JJ chronic) (NN hypertension)) (VP (VBN treated) (PP (IN with) (NP (NP (NN Labetalol)) (CC and) (NP (NP (NN hypothyroidism)) (VP (VBN treated) (PP (IN with) (NP (NN Thyroxine)))))))))) (. .)))

(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ has) (NP (NN hypertension)))))

( ( Has ( ( chronic hypertension ) ( treated ( with ( ( Labetalol and ) ( hypothyroidism ( treated ( with Thyroxine ) ) ) ) ) ) ) ) . )

( ( the patient ) ( has hypertension ) )

23ef2486-66c7-11e7-af7d-f45c89b91419

contradiction

Has chronic hypertension treated with Labetalol and hypothyroidism treated with Thyroxine.

the patient has normal blood pressure

(ROOT (S (VP (VBZ Has) (NP (NP (JJ chronic) (NN hypertension)) (VP (VBN treated) (PP (IN with) (NP (NP (NN Labetalol)) (CC and) (NP (NP (NN hypothyroidism)) (VP (VBN treated) (PP (IN with) (NP (NN Thyroxine)))))))))) (. .)))

(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ has) (NP (JJ normal) (NP (NN blood) (NN pressure))))))

( ( Has ( ( chronic hypertension ) ( treated ( with ( ( Labetalol and ) ( hypothyroidism ( treated ( with Thyroxine ) ) ) ) ) ) ) ) . )

( ( the patient ) ( has ( normal ( blood pressure ) ) ) )

23ef2648-66c7-11e7-96df-f45c89b91419

neutral

Has chronic hypertension treated with Labetalol and hypothyroidism treated with Thyroxine.

the patient has coronary artery disease

(ROOT (S (VP (VBZ Has) (NP (NP (JJ chronic) (NN hypertension)) (VP (VBN treated) (PP (IN with) (NP (NP (NN Labetalol)) (CC and) (NP (NP (NN hypothyroidism)) (VP (VBN treated) (PP (IN with) (NP (NN Thyroxine)))))))))) (. .)))

(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ has) (NP (JJ coronary) (NN artery) (NN disease)))))

( ( Has ( ( chronic hypertension ) ( treated ( with ( ( Labetalol and ) ( hypothyroidism ( treated ( with Thyroxine ) ) ) ) ) ) ) ) . )

( ( the patient ) ( has ( coronary ( artery disease ) ) ) )

23ef2808-66c7-11e7-8e38-f45c89b91419

entailment

She presented on the date of admission for workup management per her primary care physician.

the patient receives outpatient medical care.

(ROOT (S (NP (PRP She)) (VP (VBD presented) (PP (IN on) (NP (NP (DT the) (NN date)) (PP (IN of) (NP (NP (NN admission)) (PP (IN for) (NP (NP (NN workup) (NN management)) (PP (IN per) (NP (PRP$ her) (JJ primary) (NN care) (NN physician)))))))))) (. .)))

(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ receives) (NP (JJ outpatient) (JJ medical) (NN care))) (. .)))

( She ( ( presented ( on ( ( the date ) ( of ( admission ( for ( ( workup management ) ( per ( her ( primary ( care physician ) ) ) ) ) ) ) ) ) ) ) . ) )

( ( the patient ) ( ( receives ( outpatient ( medical care ) ) ) . ) )

23ef29de-66c7-11e7-95e3-f45c89b91419

contradiction

She presented on the date of admission for workup management per her primary care physician.

The patient does not have a primary medical doctor.

(ROOT (S (NP (PRP She)) (VP (VBD presented) (PP (IN on) (NP (NP (DT the) (NN date)) (PP (IN of) (NP (NP (NN admission)) (PP (IN for) (NP (NP (NN workup) (NN management)) (PP (IN per) (NP (PRP$ her) (JJ primary) (NN care) (NN physician)))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ does) (RB not) (VP (VB have) (NP (DT a) (JJ primary) (JJ medical) (NN doctor)))) (. .)))

( She ( ( presented ( on ( ( the date ) ( of ( admission ( for ( ( workup management ) ( per ( her ( primary ( care physician ) ) ) ) ) ) ) ) ) ) ) . ) )

( ( The patient ) ( ( ( does not ) ( have ( a ( primary ( medical doctor ) ) ) ) ) . ) )

23ef2d58-66c7-11e7-bb40-f45c89b91419

neutral

She presented on the date of admission for workup management per her primary care physician.

The patient has cancer.

(ROOT (S (NP (PRP She)) (VP (VBD presented) (PP (IN on) (NP (NP (DT the) (NN date)) (PP (IN of) (NP (NP (NN admission)) (PP (IN for) (NP (NP (NN workup) (NN management)) (PP (IN per) (NP (PRP$ her) (JJ primary) (NN care) (NN physician)))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NN cancer))) (. .)))

( She ( ( presented ( on ( ( the date ) ( of ( admission ( for ( ( workup management ) ( per ( her ( primary ( care physician ) ) ) ) ) ) ) ) ) ) ) . ) )

( ( The patient ) ( ( has cancer ) . ) )

23ef2f9c-66c7-11e7-a95e-f45c89b91419

entailment

Delivery proceeded via vaginal route and infant emerged with good tone, but limited respiratory effort and poor aeration.

Patient has been born with sub-par Apgar’s

(ROOT (S (S (NP (NP (NN Delivery)) (VP (VBD proceeded) (PP (IN via) (NP (NP (JJ vaginal) (NN route)) (CC and) (NP (NN infant)))))) (VP (VBD emerged) (PP (IN with) (NP (JJ good) (NN tone))))) (, ,) (CC but) (NP (NP (JJ limited) (JJ respiratory) (NN effort)) (CC and) (NP (JJ poor) (NN aeration))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (VP (VBN been) (VP (VBN born) (PP (IN with) (NP (JJ sub-par) (NNP Apgar) (POS 's))))))))

( ( ( ( ( ( Delivery ( proceeded ( via ( ( ( vaginal route ) and ) infant ) ) ) ) ( emerged ( with ( good tone ) ) ) ) , ) but ) ( ( ( limited ( respiratory effort ) ) and ) ( poor aeration ) ) ) . )

( Patient ( has ( been ( born ( with ( sub-par ( Apgar 's ) ) ) ) ) ) )

23ef3190-66c7-11e7-8c98-f45c89b91419

contradiction

Delivery proceeded via vaginal route and infant emerged with good tone, but limited respiratory effort and poor aeration.

Patient has high O2 saturations

(ROOT (S (S (NP (NP (NN Delivery)) (VP (VBD proceeded) (PP (IN via) (NP (NP (JJ vaginal) (NN route)) (CC and) (NP (NN infant)))))) (VP (VBD emerged) (PP (IN with) (NP (JJ good) (NN tone))))) (, ,) (CC but) (NP (NP (JJ limited) (JJ respiratory) (NN effort)) (CC and) (NP (JJ poor) (NN aeration))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (JJ high) (CD O2) (NNS saturations)))))

( ( ( ( ( ( Delivery ( proceeded ( via ( ( ( vaginal route ) and ) infant ) ) ) ) ( emerged ( with ( good tone ) ) ) ) , ) but ) ( ( ( limited ( respiratory effort ) ) and ) ( poor aeration ) ) ) . )

( Patient ( has ( high ( O2 saturations ) ) ) )

23ef3366-66c7-11e7-be61-f45c89b91419

neutral

Delivery proceeded via vaginal route and infant emerged with good tone, but limited respiratory effort and poor aeration.

Patient is a female infant

(ROOT (S (S (NP (NP (NN Delivery)) (VP (VBD proceeded) (PP (IN via) (NP (NP (JJ vaginal) (NN route)) (CC and) (NP (NN infant)))))) (VP (VBD emerged) (PP (IN with) (NP (JJ good) (NN tone))))) (, ,) (CC but) (NP (NP (JJ limited) (JJ respiratory) (NN effort)) (CC and) (NP (JJ poor) (NN aeration))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ is) (NP (DT a) (JJ female) (NN infant)))))

( ( ( ( ( ( Delivery ( proceeded ( via ( ( ( vaginal route ) and ) infant ) ) ) ) ( emerged ( with ( good tone ) ) ) ) , ) but ) ( ( ( limited ( respiratory effort ) ) and ) ( poor aeration ) ) ) . )

( Patient ( is ( a ( female infant ) ) ) )

23ef35d2-66c7-11e7-ac98-f45c89b91419

entailment

EMS arrived, found the patient FS noted to be 58, given [**12-19**] amp D50, BS improved to 166.

Patient has been given glucose

(ROOT (S (NP (NNP EMS)) (VP (VP (VBD arrived)) (, ,) (VP (VBD found) (SBAR (S (NP (DT the) (NN patient) (NN FS)) (VP (VBD noted) (S (VP (TO to) (VP (VB be) (NP (CD 58))))) (, ,) (VP (VBN given) (S (-LRB- -LSB-) (SYM **) (QP (CD 12-19)) (X (SYM **)) (-RRB- -RSB-) (PP (IN amp) (NP (NN D50))) (, ,) (NP (NN BS)) (VP (VBD improved) (PP (TO to) (NP (CD 166))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (VP (VBN been) (VP (VBN given) (NP (NN glucose)))))))

( EMS ( ( ( arrived , ) ( found ( ( the ( patient FS ) ) ( ( ( noted ( to ( be 58 ) ) ) , ) ( given ( -LSB- ( ** ( 12-19 ( ** ( -RSB- ( ( amp D50 ) ( , ( BS ( improved ( to 166 ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )

( Patient ( has ( been ( given glucose ) ) ) )

23ef37c8-66c7-11e7-b9f3-f45c89b91419

contradiction

EMS arrived, found the patient FS noted to be 58, given [**12-19**] amp D50, BS improved to 166.

Patient has normal glucose at baseline

(ROOT (S (NP (NNP EMS)) (VP (VP (VBD arrived)) (, ,) (VP (VBD found) (SBAR (S (NP (DT the) (NN patient) (NN FS)) (VP (VBD noted) (S (VP (TO to) (VP (VB be) (NP (CD 58))))) (, ,) (VP (VBN given) (S (-LRB- -LSB-) (SYM **) (QP (CD 12-19)) (X (SYM **)) (-RRB- -RSB-) (PP (IN amp) (NP (NN D50))) (, ,) (NP (NN BS)) (VP (VBD improved) (PP (TO to) (NP (CD 166))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (NP (JJ normal) (NN glucose)) (PP (IN at) (NP (NN baseline)))))))

( EMS ( ( ( arrived , ) ( found ( ( the ( patient FS ) ) ( ( ( noted ( to ( be 58 ) ) ) , ) ( given ( -LSB- ( ** ( 12-19 ( ** ( -RSB- ( ( amp D50 ) ( , ( BS ( improved ( to 166 ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )

( Patient ( has ( ( normal glucose ) ( at baseline ) ) ) )

23ef399c-66c7-11e7-97e6-f45c89b91419

neutral

EMS arrived, found the patient FS noted to be 58, given [**12-19**] amp D50, BS improved to 166.

Patient has diabetes

(ROOT (S (NP (NNP EMS)) (VP (VP (VBD arrived)) (, ,) (VP (VBD found) (SBAR (S (NP (DT the) (NN patient) (NN FS)) (VP (VBD noted) (S (VP (TO to) (VP (VB be) (NP (CD 58))))) (, ,) (VP (VBN given) (S (-LRB- -LSB-) (SYM **) (QP (CD 12-19)) (X (SYM **)) (-RRB- -RSB-) (PP (IN amp) (NP (NN D50))) (, ,) (NP (NN BS)) (VP (VBD improved) (PP (TO to) (NP (CD 166))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (NNS diabetes)))))

( EMS ( ( ( arrived , ) ( found ( ( the ( patient FS ) ) ( ( ( noted ( to ( be 58 ) ) ) , ) ( given ( -LSB- ( ** ( 12-19 ( ** ( -RSB- ( ( amp D50 ) ( , ( BS ( improved ( to 166 ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )

( Patient ( has diabetes ) )

23ef3b74-66c7-11e7-9f6d-f45c89b91419

entailment

His chest discomfort resolved at the outside hospital following nitrates, and there has been no recurrence of chest pain.

The patient took a arterial vasodilator.

(ROOT (S (S (NP (PRP$ His) (NN chest) (NN discomfort)) (VP (VBN resolved) (PP (IN at) (NP (NP (DT the) (JJ outside) (NN hospital)) (PP (VBG following) (NP (NNS nitrates))))))) (, ,) (CC and) (S (NP (EX there)) (VP (VBZ has) (VP (VBN been) (NP (NP (DT no) (NN recurrence)) (PP (IN of) (NP (NN chest) (NN pain))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBD took) (NP (DT a) (JJ arterial) (NN vasodilator))) (. .)))

( ( ( ( ( ( His ( chest discomfort ) ) ( resolved ( at ( ( the ( outside hospital ) ) ( following nitrates ) ) ) ) ) , ) and ) ( there ( has ( been ( ( no recurrence ) ( of ( chest pain ) ) ) ) ) ) ) . )

( ( The patient ) ( ( took ( a ( arterial vasodilator ) ) ) . ) )

23ef3e4c-66c7-11e7-ace7-f45c89b91419

contradiction

His chest discomfort resolved at the outside hospital following nitrates, and there has been no recurrence of chest pain.

The patient has no chest pain.

(ROOT (S (S (NP (PRP$ His) (NN chest) (NN discomfort)) (VP (VBN resolved) (PP (IN at) (NP (NP (DT the) (JJ outside) (NN hospital)) (PP (VBG following) (NP (NNS nitrates))))))) (, ,) (CC and) (S (NP (EX there)) (VP (VBZ has) (VP (VBN been) (NP (NP (DT no) (NN recurrence)) (PP (IN of) (NP (NN chest) (NN pain))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (DT no) (NN chest) (NN pain))) (. .)))

( ( ( ( ( ( His ( chest discomfort ) ) ( resolved ( at ( ( the ( outside hospital ) ) ( following nitrates ) ) ) ) ) , ) and ) ( there ( has ( been ( ( no recurrence ) ( of ( chest pain ) ) ) ) ) ) ) . )

( ( The patient ) ( ( has ( no ( chest pain ) ) ) . ) )

23ef4040-66c7-11e7-884f-f45c89b91419

neutral

His chest discomfort resolved at the outside hospital following nitrates, and there has been no recurrence of chest pain.

The patient has stable angina.

(ROOT (S (S (NP (PRP$ His) (NN chest) (NN discomfort)) (VP (VBN resolved) (PP (IN at) (NP (NP (DT the) (JJ outside) (NN hospital)) (PP (VBG following) (NP (NNS nitrates))))))) (, ,) (CC and) (S (NP (EX there)) (VP (VBZ has) (VP (VBN been) (NP (NP (DT no) (NN recurrence)) (PP (IN of) (NP (NN chest) (NN pain))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (JJ stable) (NN angina))) (. .)))

( ( ( ( ( ( His ( chest discomfort ) ) ( resolved ( at ( ( the ( outside hospital ) ) ( following nitrates ) ) ) ) ) , ) and ) ( there ( has ( been ( ( no recurrence ) ( of ( chest pain ) ) ) ) ) ) ) . )

( ( The patient ) ( ( has ( stable angina ) ) . ) )

23ef425c-66c7-11e7-a88d-f45c89b91419

entailment

Over the past two weeks has barely been able to ambulate at all, has had increased frequency of falls (most recently last night when getting up to go to the BR during the night, no LOC).

patient has multiple falls

(ROOT (S (S (PP (IN Over) (NP (DT the) (JJ past) (CD two) (NNS weeks))) (VP (VBZ has) (ADVP (RB barely)) (VP (VBN been) (ADJP (JJ able) (S (VP (TO to) (VP (VB ambulate) (ADVP (IN at) (DT all))))))))) (, ,) (VP (VBZ has) (VP (VBN had) (NP (NP (VBN increased) (NN frequency)) (PP (IN of) (FRAG (VBZ falls) (-LRB- -LRB-) (ADVP (RBS most) (RB recently)) (NP (JJ last) (NN night)) (SBAR (WHADVP (WRB when)) (FRAG (S (VP (VBG getting) (ADVP (RP up) (S (VP (TO to) (VP (VB go) (PP (TO to) (NP (DT the) (NN BR))) (PP (IN during) (NP (DT the) (NN night))))))))) (, ,) (NP (DT no) (NN LOC)))) (-RRB- -RRB-)))))) (. .)))

(ROOT (S (NP (NN patient)) (VP (VBZ has) (FRAG (S (ADJP (JJ multiple)) (VP (VBZ falls)))))))

( ( ( Over ( the ( past ( two weeks ) ) ) ) ( ( has barely ) ( been ( able ( to ( ambulate ( at all ) ) ) ) ) ) ) ( , ( ( has ( had ( ( increased frequency ) ( of ( falls ( -LRB- ( ( most recently ) ( ( last night ) ( ( when ( ( getting ( up ( to ( ( go ( to ( the BR ) ) ) ( during ( the night ) ) ) ) ) ) ( , ( no LOC ) ) ) ) -RRB- ) ) ) ) ) ) ) ) ) . ) ) )

( patient ( has ( multiple falls ) ) )

23ef4478-66c7-11e7-bf62-f45c89b91419

contradiction

Over the past two weeks has barely been able to ambulate at all, has had increased frequency of falls (most recently last night when getting up to go to the BR during the night, no LOC).

patient has normal ambulation

(ROOT (S (S (PP (IN Over) (NP (DT the) (JJ past) (CD two) (NNS weeks))) (VP (VBZ has) (ADVP (RB barely)) (VP (VBN been) (ADJP (JJ able) (S (VP (TO to) (VP (VB ambulate) (ADVP (IN at) (DT all))))))))) (, ,) (VP (VBZ has) (VP (VBN had) (NP (NP (VBN increased) (NN frequency)) (PP (IN of) (FRAG (VBZ falls) (-LRB- -LRB-) (ADVP (RBS most) (RB recently)) (NP (JJ last) (NN night)) (SBAR (WHADVP (WRB when)) (FRAG (S (VP (VBG getting) (ADVP (RP up) (S (VP (TO to) (VP (VB go) (PP (TO to) (NP (DT the) (NN BR))) (PP (IN during) (NP (DT the) (NN night))))))))) (, ,) (NP (DT no) (NN LOC)))) (-RRB- -RRB-)))))) (. .)))

(ROOT (S (NP (NN patient)) (VP (VBZ has) (NP (JJ normal) (NN ambulation)))))

( ( ( Over ( the ( past ( two weeks ) ) ) ) ( ( has barely ) ( been ( able ( to ( ambulate ( at all ) ) ) ) ) ) ) ( , ( ( has ( had ( ( increased frequency ) ( of ( falls ( -LRB- ( ( most recently ) ( ( last night ) ( ( when ( ( getting ( up ( to ( ( go ( to ( the BR ) ) ) ( during ( the night ) ) ) ) ) ) ( , ( no LOC ) ) ) ) -RRB- ) ) ) ) ) ) ) ) ) . ) ) )

( patient ( has ( normal ambulation ) ) )

23ef4718-66c7-11e7-9d81-f45c89b91419

neutral

Over the past two weeks has barely been able to ambulate at all, has had increased frequency of falls (most recently last night when getting up to go to the BR during the night, no LOC).

patient has normal pressure hydrocephalus

(ROOT (S (S (PP (IN Over) (NP (DT the) (JJ past) (CD two) (NNS weeks))) (VP (VBZ has) (ADVP (RB barely)) (VP (VBN been) (ADJP (JJ able) (S (VP (TO to) (VP (VB ambulate) (ADVP (IN at) (DT all))))))))) (, ,) (VP (VBZ has) (VP (VBN had) (NP (NP (VBN increased) (NN frequency)) (PP (IN of) (FRAG (VBZ falls) (-LRB- -LRB-) (ADVP (RBS most) (RB recently)) (NP (JJ last) (NN night)) (SBAR (WHADVP (WRB when)) (FRAG (S (VP (VBG getting) (ADVP (RP up) (S (VP (TO to) (VP (VB go) (PP (TO to) (NP (DT the) (NN BR))) (PP (IN during) (NP (DT the) (NN night))))))))) (, ,) (NP (DT no) (NN LOC)))) (-RRB- -RRB-)))))) (. .)))

(ROOT (S (NP (NN patient)) (VP (VBZ has) (NP (JJ normal) (NN pressure) (NN hydrocephalus)))))

( ( ( Over ( the ( past ( two weeks ) ) ) ) ( ( has barely ) ( been ( able ( to ( ambulate ( at all ) ) ) ) ) ) ) ( , ( ( has ( had ( ( increased frequency ) ( of ( falls ( -LRB- ( ( most recently ) ( ( last night ) ( ( when ( ( getting ( up ( to ( ( go ( to ( the BR ) ) ) ( during ( the night ) ) ) ) ) ) ( , ( no LOC ) ) ) ) -RRB- ) ) ) ) ) ) ) ) ) . ) ) )

( patient ( has ( normal ( pressure hydrocephalus ) ) ) )

23ef4914-66c7-11e7-ad08-f45c89b91419

entailment

He was noted to have increased filling pressures, with a pulmonary capillary wedge pressure of 26, pulmonary artery pressure of 56%.

Patient has pulmonary HTN

(ROOT (S (NP (PRP He)) (VP (VBD was) (VP (VBN noted) (S (VP (TO to) (VP (VB have) (NP (NP (VBN increased) (VBG filling) (NNS pressures)) (, ,) (FRAG (PP (IN with) (NP (NP (DT a) (JJ pulmonary) (JJ capillary) (NN wedge) (NN pressure)) (PP (IN of) (NP (CD 26))))) (, ,) (NP (NP (JJ pulmonary) (NN artery) (NN pressure)) (PP (IN of) (NP (CD 56) (NN %))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (JJ pulmonary) (NN HTN)))))

( He ( ( was ( noted ( to ( have ( ( ( increased ( filling pressures ) ) , ) ( ( with ( ( a ( pulmonary ( capillary ( wedge pressure ) ) ) ) ( of 26 ) ) ) ( , ( ( pulmonary ( artery pressure ) ) ( of ( 56 % ) ) ) ) ) ) ) ) ) ) . ) )

( Patient ( has ( pulmonary HTN ) ) )

23ef4be4-66c7-11e7-ae45-f45c89b91419

contradiction

He was noted to have increased filling pressures, with a pulmonary capillary wedge pressure of 26, pulmonary artery pressure of 56%.

Patient has normal CTA of the chest

(ROOT (S (NP (PRP He)) (VP (VBD was) (VP (VBN noted) (S (VP (TO to) (VP (VB have) (NP (NP (VBN increased) (VBG filling) (NNS pressures)) (, ,) (FRAG (PP (IN with) (NP (NP (DT a) (JJ pulmonary) (JJ capillary) (NN wedge) (NN pressure)) (PP (IN of) (NP (CD 26))))) (, ,) (NP (NP (JJ pulmonary) (NN artery) (NN pressure)) (PP (IN of) (NP (CD 56) (NN %))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (NP (JJ normal) (NN CTA)) (PP (IN of) (NP (DT the) (NN chest)))))))

( He ( ( was ( noted ( to ( have ( ( ( increased ( filling pressures ) ) , ) ( ( with ( ( a ( pulmonary ( capillary ( wedge pressure ) ) ) ) ( of 26 ) ) ) ( , ( ( pulmonary ( artery pressure ) ) ( of ( 56 % ) ) ) ) ) ) ) ) ) ) . ) )

( Patient ( has ( ( normal CTA ) ( of ( the chest ) ) ) ) )

23ef4de4-66c7-11e7-b5f2-f45c89b91419

neutral

He was noted to have increased filling pressures, with a pulmonary capillary wedge pressure of 26, pulmonary artery pressure of 56%.

Patient has RVH

(ROOT (S (NP (PRP He)) (VP (VBD was) (VP (VBN noted) (S (VP (TO to) (VP (VB have) (NP (NP (VBN increased) (VBG filling) (NNS pressures)) (, ,) (FRAG (PP (IN with) (NP (NP (DT a) (JJ pulmonary) (JJ capillary) (NN wedge) (NN pressure)) (PP (IN of) (NP (CD 26))))) (, ,) (NP (NP (JJ pulmonary) (NN artery) (NN pressure)) (PP (IN of) (NP (CD 56) (NN %))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (NN RVH)))))

( He ( ( was ( noted ( to ( have ( ( ( increased ( filling pressures ) ) , ) ( ( with ( ( a ( pulmonary ( capillary ( wedge pressure ) ) ) ) ( of 26 ) ) ) ( , ( ( pulmonary ( artery pressure ) ) ( of ( 56 % ) ) ) ) ) ) ) ) ) ) . ) )

( Patient ( has RVH ) )

23ef4fec-66c7-11e7-8e56-f45c89b91419

entailment

4. seizure d/o 5. chronic type A aortic dissection s/p repair [**4-17**] w/ most recent imagining [**3208-11-28**] showing no progression 6. h/o cellulitis 7.

Patient has an acute finding

(ROOT (S (VP (LST (LS 4) (. .)) (S (VP (NN seizure) (NP (NN d/o) (CD 5) (. .) (VP (JJ chronic) (S (VP (NN type) (NP (NP (DT A) (JJ aortic) (NN dissection) (NN s/p) (NN repair)) (FRAG (-LRB- -LSB-) (NP (SYM **) (CD 4-17) (X (SYM **)) (-RRB- -RSB-) (SYM w) (: /) (ADJP (RBS most) (JJ recent) (VBG imagining)) (-LRB- -LSB-) (SYM **) (CD 3208-11-28) (X (SYM **)) (-RRB- -RSB-) (S (VP (VBG showing) (NP (DT no) (NN progression) (CD 6) (. .) (NN h/o) (NN cellulitis) (CD 7)))))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (DT an) (JJ acute) (NN finding)))))

( ( ( 4 . ) ( seizure ( ( ( d/o 5 ) . ) ( chronic ( type ( ( A ( aortic ( dissection ( s/p repair ) ) ) ) ( -LSB- ( ** ( 4-17 ( ** ( -RSB- ( w ( / ( ( ( ( ( ( ( most ( recent imagining ) ) -LSB- ) ** ) 3208-11-28 ) ** ) -RSB- ) ( showing ( no ( progression ( 6 ( . ( h/o ( cellulitis 7 ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . )

( Patient ( has ( an ( acute finding ) ) ) )

23ef5292-66c7-11e7-8b1b-f45c89b91419

contradiction

4. seizure d/o 5. chronic type A aortic dissection s/p repair [**4-17**] w/ most recent imagining [**3208-11-28**] showing no progression 6. h/o cellulitis 7.

Patient has normal imaging

(ROOT (S (VP (LST (LS 4) (. .)) (S (VP (NN seizure) (NP (NN d/o) (CD 5) (. .) (VP (JJ chronic) (S (VP (NN type) (NP (NP (DT A) (JJ aortic) (NN dissection) (NN s/p) (NN repair)) (FRAG (-LRB- -LSB-) (NP (SYM **) (CD 4-17) (X (SYM **)) (-RRB- -RSB-) (SYM w) (: /) (ADJP (RBS most) (JJ recent) (VBG imagining)) (-LRB- -LSB-) (SYM **) (CD 3208-11-28) (X (SYM **)) (-RRB- -RSB-) (S (VP (VBG showing) (NP (DT no) (NN progression) (CD 6) (. .) (NN h/o) (NN cellulitis) (CD 7)))))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (JJ normal) (NN imaging)))))

( ( ( 4 . ) ( seizure ( ( ( d/o 5 ) . ) ( chronic ( type ( ( A ( aortic ( dissection ( s/p repair ) ) ) ) ( -LSB- ( ** ( 4-17 ( ** ( -RSB- ( w ( / ( ( ( ( ( ( ( most ( recent imagining ) ) -LSB- ) ** ) 3208-11-28 ) ** ) -RSB- ) ( showing ( no ( progression ( 6 ( . ( h/o ( cellulitis 7 ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . )

( Patient ( has ( normal imaging ) ) )

23ef5800-66c7-11e7-b887-f45c89b91419

neutral

4. seizure d/o 5. chronic type A aortic dissection s/p repair [**4-17**] w/ most recent imagining [**3208-11-28**] showing no progression 6. h/o cellulitis 7.

Patient has a surgical condition

(ROOT (S (VP (LST (LS 4) (. .)) (S (VP (NN seizure) (NP (NN d/o) (CD 5) (. .) (VP (JJ chronic) (S (VP (NN type) (NP (NP (DT A) (JJ aortic) (NN dissection) (NN s/p) (NN repair)) (FRAG (-LRB- -LSB-) (NP (SYM **) (CD 4-17) (X (SYM **)) (-RRB- -RSB-) (SYM w) (: /) (ADJP (RBS most) (JJ recent) (VBG imagining)) (-LRB- -LSB-) (SYM **) (CD 3208-11-28) (X (SYM **)) (-RRB- -RSB-) (S (VP (VBG showing) (NP (DT no) (NN progression) (CD 6) (. .) (NN h/o) (NN cellulitis) (CD 7)))))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (DT a) (JJ surgical) (NN condition)))))

( ( ( 4 . ) ( seizure ( ( ( d/o 5 ) . ) ( chronic ( type ( ( A ( aortic ( dissection ( s/p repair ) ) ) ) ( -LSB- ( ** ( 4-17 ( ** ( -RSB- ( w ( / ( ( ( ( ( ( ( most ( recent imagining ) ) -LSB- ) ** ) 3208-11-28 ) ** ) -RSB- ) ( showing ( no ( progression ( 6 ( . ( h/o ( cellulitis 7 ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . )

( Patient ( has ( a ( surgical condition ) ) ) )

23ef59de-66c7-11e7-98ff-f45c89b91419

entailment

Head, eyes, ears, nose and throat: The anterior fontanel was flat and soft.

The patient is an infant.

(ROOT (S (NP (NP (NNP Head)) (, ,) (NP (NNS eyes)) (, ,) (NP (NNS ears)) (, ,) (NP (NN nose) (CC and) (NN throat)) (: :)) (NP (DT The) (JJ anterior) (NN fontanel)) (VP (VBD was) (ADJP (ADJP (JJ flat)) (CC and) (ADJP (JJ soft)))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ is) (NP (DT an) (NN infant))) (. .)))

( ( ( ( ( ( ( ( Head , ) eyes ) , ) ears ) , ) ( ( nose and ) throat ) ) : ) ( ( The ( anterior fontanel ) ) ( ( was ( ( flat and ) soft ) ) . ) ) )

( ( The patient ) ( ( is ( an infant ) ) . ) )

23ef5c1a-66c7-11e7-a6d1-f45c89b91419

contradiction

Head, eyes, ears, nose and throat: The anterior fontanel was flat and soft.

The patient has exam findings of craniosynostosis.

(ROOT (S (NP (NP (NNP Head)) (, ,) (NP (NNS eyes)) (, ,) (NP (NNS ears)) (, ,) (NP (NN nose) (CC and) (NN throat)) (: :)) (NP (DT The) (JJ anterior) (NN fontanel)) (VP (VBD was) (ADJP (ADJP (JJ flat)) (CC and) (ADJP (JJ soft)))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NP (NN exam) (NNS findings)) (PP (IN of) (NP (NN craniosynostosis))))) (. .)))

( ( ( ( ( ( ( ( Head , ) eyes ) , ) ears ) , ) ( ( nose and ) throat ) ) : ) ( ( The ( anterior fontanel ) ) ( ( was ( ( flat and ) soft ) ) . ) ) )

( ( The patient ) ( ( has ( ( exam findings ) ( of craniosynostosis ) ) ) . ) )

23ef5df0-66c7-11e7-a2a4-f45c89b91419

neutral

Head, eyes, ears, nose and throat: The anterior fontanel was flat and soft.

The patient has normal development.

(ROOT (S (NP (NP (NNP Head)) (, ,) (NP (NNS eyes)) (, ,) (NP (NNS ears)) (, ,) (NP (NN nose) (CC and) (NN throat)) (: :)) (NP (DT The) (JJ anterior) (NN fontanel)) (VP (VBD was) (ADJP (ADJP (JJ flat)) (CC and) (ADJP (JJ soft)))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (JJ normal) (NN development))) (. .)))

( ( ( ( ( ( ( ( Head , ) eyes ) , ) ears ) , ) ( ( nose and ) throat ) ) : ) ( ( The ( anterior fontanel ) ) ( ( was ( ( flat and ) soft ) ) . ) ) )

( ( The patient ) ( ( has ( normal development ) ) . ) )

23ef6070-66c7-11e7-8fb3-f45c89b91419

entailment

No LOC, no EtOH.

there is no alcohol

(ROOT (NP (NP (DT No) (NN LOC)) (, ,) (NP (DT no) (NN EtOH)) (. .)))

(ROOT (S (NP (EX there)) (VP (VBZ is) (NP (DT no) (NN alcohol)))))

( ( ( ( No LOC ) , ) ( no EtOH ) ) . )

( there ( is ( no alcohol ) ) )

23ef6214-66c7-11e7-a879-f45c89b91419

contradiction

No LOC, no EtOH.

screen is positive for alcohol

(ROOT (NP (NP (DT No) (NN LOC)) (, ,) (NP (DT no) (NN EtOH)) (. .)))

(ROOT (S (NP (NN screen)) (VP (VBZ is) (ADJP (JJ positive)) (PP (IN for) (NP (NN alcohol))))))

( ( ( ( No LOC ) , ) ( no EtOH ) ) . )

( screen ( ( is positive ) ( for alcohol ) ) )

23ef63a4-66c7-11e7-a477-f45c89b91419

neutral

No LOC, no EtOH.

there are no drugs

(ROOT (NP (NP (DT No) (NN LOC)) (, ,) (NP (DT no) (NN EtOH)) (. .)))

(ROOT (S (NP (EX there)) (VP (VBP are) (NP (DT no) (NNS drugs)))))

( ( ( ( No LOC ) , ) ( no EtOH ) ) . )

( there ( are ( no drugs ) ) )

23ef65ac-66c7-11e7-9a6c-f45c89b91419

entailment

She had intended to call her PCP today, however, symptoms began when she awoke at midnight last night so she came to the emergency room.

Patient has new symptoms

(ROOT (S (S (NP (PRP She)) (VP (VBD had) (VP (VBN intended) (S (VP (TO to) (VP (VB call) (NP (PRP$ her) (NN PCP)) (NP (NN today)))))))) (, ,) (ADVP (RB however)) (, ,) (S (NP (NNS symptoms)) (VP (VBD began) (SBAR (WHADVP (WRB when)) (S (NP (PRP she)) (VP (VBD awoke) (PP (IN at) (NP (NN midnight))) (NP (JJ last) (NN night)) (SBAR (IN so) (S (NP (PRP she)) (VP (VBD came) (PP (TO to) (NP (DT the) (NN emergency) (NN room))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (JJ new) (NNS symptoms)))))

( ( ( ( ( ( She ( had ( intended ( to ( ( call ( her PCP ) ) today ) ) ) ) ) , ) however ) , ) ( symptoms ( began ( when ( she ( ( ( awoke ( at midnight ) ) ( last night ) ) ( so ( she ( came ( to ( the ( emergency room ) ) ) ) ) ) ) ) ) ) ) ) . )

( Patient ( has ( new symptoms ) ) )

23ef67ca-66c7-11e7-96cd-f45c89b91419

contradiction

She had intended to call her PCP today, however, symptoms began when she awoke at midnight last night so she came to the emergency room.

Patient has nothing to report

(ROOT (S (S (NP (PRP She)) (VP (VBD had) (VP (VBN intended) (S (VP (TO to) (VP (VB call) (NP (PRP$ her) (NN PCP)) (NP (NN today)))))))) (, ,) (ADVP (RB however)) (, ,) (S (NP (NNS symptoms)) (VP (VBD began) (SBAR (WHADVP (WRB when)) (S (NP (PRP she)) (VP (VBD awoke) (PP (IN at) (NP (NN midnight))) (NP (JJ last) (NN night)) (SBAR (IN so) (S (NP (PRP she)) (VP (VBD came) (PP (TO to) (NP (DT the) (NN emergency) (NN room))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (NP (NN nothing)) (SBAR (S (VP (TO to) (VP (VB report)))))))))

( ( ( ( ( ( She ( had ( intended ( to ( ( call ( her PCP ) ) today ) ) ) ) ) , ) however ) , ) ( symptoms ( began ( when ( she ( ( ( awoke ( at midnight ) ) ( last night ) ) ( so ( she ( came ( to ( the ( emergency room ) ) ) ) ) ) ) ) ) ) ) ) . )

( Patient ( has ( nothing ( to report ) ) ) )

23ef6a66-66c7-11e7-9d4d-f45c89b91419

neutral

She had intended to call her PCP today, however, symptoms began when she awoke at midnight last night so she came to the emergency room.

Patient has acute pain

(ROOT (S (S (NP (PRP She)) (VP (VBD had) (VP (VBN intended) (S (VP (TO to) (VP (VB call) (NP (PRP$ her) (NN PCP)) (NP (NN today)))))))) (, ,) (ADVP (RB however)) (, ,) (S (NP (NNS symptoms)) (VP (VBD began) (SBAR (WHADVP (WRB when)) (S (NP (PRP she)) (VP (VBD awoke) (PP (IN at) (NP (NN midnight))) (NP (JJ last) (NN night)) (SBAR (IN so) (S (NP (PRP she)) (VP (VBD came) (PP (TO to) (NP (DT the) (NN emergency) (NN room))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (JJ acute) (NN pain)))))

( ( ( ( ( ( She ( had ( intended ( to ( ( call ( her PCP ) ) today ) ) ) ) ) , ) however ) , ) ( symptoms ( began ( when ( she ( ( ( awoke ( at midnight ) ) ( last night ) ) ( so ( she ( came ( to ( the ( emergency room ) ) ) ) ) ) ) ) ) ) ) ) . )

( Patient ( has ( acute pain ) ) )

23ef6d9c-66c7-11e7-acb2-f45c89b91419

entailment

Per his report he completed antibiotics on Tuesday although he is unsure if this was the [** Location **]usly prescribed Linezolid or a different medication.

The patient is taking medication for an infection.

(ROOT (FRAG (PP (IN Per) (NP (NP (PRP$ his) (NN report)) (SBAR (S (NP (PRP he)) (VP (VBD completed) (NP (NNS antibiotics)) (PP (IN on) (NP (NNP Tuesday))) (SBAR (IN although) (S (NP (PRP he)) (VP (VBZ is) (ADJP (JJ unsure) (SBAR (IN if) (S (NP (DT this)) (VP (VBD was) (NP (DT the) (-LRB- -LSB-) (NP (NP (SYM **) (NNP Location) (X (SYM **)) (-RRB- -RSB-) (ADJP (RB usly) (VBN prescribed)) (NN Linezolid)) (CC or) (NP (DT a) (JJ different) (NN medication)))))))))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ is) (VP (VBG taking) (NP (NN medication)) (PP (IN for) (NP (DT an) (NN infection))))) (. .)))

( ( Per ( ( his report ) ( he ( ( ( completed antibiotics ) ( on Tuesday ) ) ( although ( he ( is ( unsure ( if ( this ( was ( the ( -LSB- ( ( ( ** ( Location ( ** ( -RSB- ( ( usly prescribed ) Linezolid ) ) ) ) ) or ) ( a ( different medication ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . )

( ( The patient ) ( ( is ( ( taking medication ) ( for ( an infection ) ) ) ) . ) )

23ef7100-66c7-11e7-a6c9-f45c89b91419

contradiction

Per his report he completed antibiotics on Tuesday although he is unsure if this was the [** Location **]usly prescribed Linezolid or a different medication.

The patient does not have an infection.

(ROOT (FRAG (PP (IN Per) (NP (NP (PRP$ his) (NN report)) (SBAR (S (NP (PRP he)) (VP (VBD completed) (NP (NNS antibiotics)) (PP (IN on) (NP (NNP Tuesday))) (SBAR (IN although) (S (NP (PRP he)) (VP (VBZ is) (ADJP (JJ unsure) (SBAR (IN if) (S (NP (DT this)) (VP (VBD was) (NP (DT the) (-LRB- -LSB-) (NP (NP (SYM **) (NNP Location) (X (SYM **)) (-RRB- -RSB-) (ADJP (RB usly) (VBN prescribed)) (NN Linezolid)) (CC or) (NP (DT a) (JJ different) (NN medication)))))))))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ does) (RB not) (VP (VB have) (NP (DT an) (NN infection)))) (. .)))

( ( Per ( ( his report ) ( he ( ( ( completed antibiotics ) ( on Tuesday ) ) ( although ( he ( is ( unsure ( if ( this ( was ( the ( -LSB- ( ( ( ** ( Location ( ** ( -RSB- ( ( usly prescribed ) Linezolid ) ) ) ) ) or ) ( a ( different medication ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . )

( ( The patient ) ( ( ( does not ) ( have ( an infection ) ) ) . ) )

23ef7614-66c7-11e7-ae9c-f45c89b91419

neutral

Per his report he completed antibiotics on Tuesday although he is unsure if this was the [** Location **]usly prescribed Linezolid or a different medication.

The patient had cellulitis.

(ROOT (FRAG (PP (IN Per) (NP (NP (PRP$ his) (NN report)) (SBAR (S (NP (PRP he)) (VP (VBD completed) (NP (NNS antibiotics)) (PP (IN on) (NP (NNP Tuesday))) (SBAR (IN although) (S (NP (PRP he)) (VP (VBZ is) (ADJP (JJ unsure) (SBAR (IN if) (S (NP (DT this)) (VP (VBD was) (NP (DT the) (-LRB- -LSB-) (NP (NP (SYM **) (NNP Location) (X (SYM **)) (-RRB- -RSB-) (ADJP (RB usly) (VBN prescribed)) (NN Linezolid)) (CC or) (NP (DT a) (JJ different) (NN medication)))))))))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBD had) (NP (NNS cellulitis))) (. .)))

( ( Per ( ( his report ) ( he ( ( ( completed antibiotics ) ( on Tuesday ) ) ( although ( he ( is ( unsure ( if ( this ( was ( the ( -LSB- ( ( ( ** ( Location ( ** ( -RSB- ( ( usly prescribed ) Linezolid ) ) ) ) ) or ) ( a ( different medication ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . )

( ( The patient ) ( ( had cellulitis ) . ) )

23ef79f4-66c7-11e7-b70d-f45c89b91419

entailment

He is also s/p removal of a PD catheter 2 days PTA at [**Hospital1 1998**].

He had a peritoneal dialysis catheter

(ROOT (S (NP (PRP He)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (JJ s/p) (NN removal)) (PP (IN of) (NP (NP (DT a) (NN PD) (NN catheter) (CD 2) (NNS days)) (NP (NNP PTA)))) (PP (IN at) (FRAG (-LRB- -LSB-) (PP (SYM **) (NP (NP (NN Hospital1) (CD 1998)) (PRN (X (SYM **)) (-RRB- -RSB-)))))))) (. .)))

(ROOT (S (NP (PRP He)) (VP (VBD had) (NP (DT a) (JJ peritoneal) (NN dialysis) (NN catheter)))))

( He ( ( ( is also ) ( ( ( s/p removal ) ( of ( ( a ( PD ( catheter ( 2 days ) ) ) ) PTA ) ) ) ( at ( -LSB- ( ** ( ( Hospital1 1998 ) ( ** -RSB- ) ) ) ) ) ) ) . ) )

( He ( had ( a ( peritoneal ( dialysis catheter ) ) ) ) )

23ef7cde-66c7-11e7-9d1a-f45c89b91419

contradiction

He is also s/p removal of a PD catheter 2 days PTA at [**Hospital1 1998**].

No history of renal dysfunction

(ROOT (S (NP (PRP He)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (JJ s/p) (NN removal)) (PP (IN of) (NP (NP (DT a) (NN PD) (NN catheter) (CD 2) (NNS days)) (NP (NNP PTA)))) (PP (IN at) (FRAG (-LRB- -LSB-) (PP (SYM **) (NP (NP (NN Hospital1) (CD 1998)) (PRN (X (SYM **)) (-RRB- -RSB-)))))))) (. .)))

(ROOT (NP (NP (DT No) (NN history)) (PP (IN of) (NP (JJ renal) (NN dysfunction)))))

( He ( ( ( is also ) ( ( ( s/p removal ) ( of ( ( a ( PD ( catheter ( 2 days ) ) ) ) PTA ) ) ) ( at ( -LSB- ( ** ( ( Hospital1 1998 ) ( ** -RSB- ) ) ) ) ) ) ) . ) )

( ( No history ) ( of ( renal dysfunction ) ) )

23ef7f4c-66c7-11e7-bed0-f45c89b91419

neutral

He is also s/p removal of a PD catheter 2 days PTA at [**Hospital1 1998**].

History of renal stenosis

(ROOT (S (NP (PRP He)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (JJ s/p) (NN removal)) (PP (IN of) (NP (NP (DT a) (NN PD) (NN catheter) (CD 2) (NNS days)) (NP (NNP PTA)))) (PP (IN at) (FRAG (-LRB- -LSB-) (PP (SYM **) (NP (NP (NN Hospital1) (CD 1998)) (PRN (X (SYM **)) (-RRB- -RSB-)))))))) (. .)))

(ROOT (NP (NP (NN History)) (PP (IN of) (NP (JJ renal) (NN stenosis)))))

( He ( ( ( is also ) ( ( ( s/p removal ) ( of ( ( a ( PD ( catheter ( 2 days ) ) ) ) PTA ) ) ) ( at ( -LSB- ( ** ( ( Hospital1 1998 ) ( ** -RSB- ) ) ) ) ) ) ) . ) )

( History ( of ( renal stenosis ) ) )

23ef81b8-66c7-11e7-b102-f45c89b91419

entailment

Suspected gastric outlet obstruction/partial SBO due to SMA syndrome suggested on radiographic studies, although duodenal narrowing not ap[** Location **]ted on repeat EGD.

Imaging demonstrates a narrowed angle between the SMA and the duodenum.

(ROOT (S (NP (NP (JJ Suspected) (JJ gastric) (NN outlet) (JJ obstruction/partial) (NN SBO)) (ADJP (JJ due) (PP (TO to) (NP (NN SMA) (NN syndrome))))) (VP (VBD suggested) (PP (IN on) (NP (JJ radiographic) (NNS studies))) (, ,) (SBAR (IN although) (NP (NP (JJ duodenal) (NN narrowing) (RB not) (NN ap)) (PRN (-LRB- -LSB-) (NP (SYM **) (NNP Location) (X (SYM **)) (SBAR (-RRB- -RSB-) (S (VP (VBN ted) (PP (IN on) (NP (NN repeat) (NN EGD))))))))))) (. .)))

(ROOT (S (NP (NNP Imaging)) (VP (VBZ demonstrates) (NP (NP (DT a) (VBN narrowed) (NN angle)) (PP (IN between) (NP (NP (DT the) (NN SMA)) (CC and) (NP (DT the) (NN duodenum)))))) (. .)))

( ( ( Suspected ( gastric ( outlet ( obstruction/partial SBO ) ) ) ) ( due ( to ( SMA syndrome ) ) ) ) ( ( ( ( suggested ( on ( radiographic studies ) ) ) , ) ( although ( ( duodenal ( narrowing ( not ap ) ) ) ( -LSB- ( ** ( ( Location ** ) ( -RSB- ( ted ( on ( repeat EGD ) ) ) ) ) ) ) ) ) ) . ) )

( Imaging ( ( demonstrates ( ( a ( narrowed angle ) ) ( between ( ( ( the SMA ) and ) ( the duodenum ) ) ) ) ) . ) )

23ef83dc-66c7-11e7-8b90-f45c89b91419

contradiction

Suspected gastric outlet obstruction/partial SBO due to SMA syndrome suggested on radiographic studies, although duodenal narrowing not ap[** Location **]ted on repeat EGD.

The patient has a wide angle between the SMA and the aorta.

(ROOT (S (NP (NP (JJ Suspected) (JJ gastric) (NN outlet) (JJ obstruction/partial) (NN SBO)) (ADJP (JJ due) (PP (TO to) (NP (NN SMA) (NN syndrome))))) (VP (VBD suggested) (PP (IN on) (NP (JJ radiographic) (NNS studies))) (, ,) (SBAR (IN although) (NP (NP (JJ duodenal) (NN narrowing) (RB not) (NN ap)) (PRN (-LRB- -LSB-) (NP (SYM **) (NNP Location) (X (SYM **)) (SBAR (-RRB- -RSB-) (S (VP (VBN ted) (PP (IN on) (NP (NN repeat) (NN EGD))))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NP (DT a) (JJ wide) (NN angle)) (PP (IN between) (NP (NP (DT the) (NN SMA)) (CC and) (NP (DT the) (NN aorta)))))) (. .)))

( ( ( Suspected ( gastric ( outlet ( obstruction/partial SBO ) ) ) ) ( due ( to ( SMA syndrome ) ) ) ) ( ( ( ( suggested ( on ( radiographic studies ) ) ) , ) ( although ( ( duodenal ( narrowing ( not ap ) ) ) ( -LSB- ( ** ( ( Location ** ) ( -RSB- ( ted ( on ( repeat EGD ) ) ) ) ) ) ) ) ) ) . ) )

( ( The patient ) ( ( has ( ( a ( wide angle ) ) ( between ( ( ( the SMA ) and ) ( the aorta ) ) ) ) ) . ) )

23ef85e6-66c7-11e7-867b-f45c89b91419

neutral

Suspected gastric outlet obstruction/partial SBO due to SMA syndrome suggested on radiographic studies, although duodenal narrowing not ap[** Location **]ted on repeat EGD.

The patient has had recent weight loss.

(ROOT (S (NP (NP (JJ Suspected) (JJ gastric) (NN outlet) (JJ obstruction/partial) (NN SBO)) (ADJP (JJ due) (PP (TO to) (NP (NN SMA) (NN syndrome))))) (VP (VBD suggested) (PP (IN on) (NP (JJ radiographic) (NNS studies))) (, ,) (SBAR (IN although) (NP (NP (JJ duodenal) (NN narrowing) (RB not) (NN ap)) (PRN (-LRB- -LSB-) (NP (SYM **) (NNP Location) (X (SYM **)) (SBAR (-RRB- -RSB-) (S (VP (VBN ted) (PP (IN on) (NP (NN repeat) (NN EGD))))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (VBN had) (JJ recent) (NN weight) (NN loss))) (. .)))

( ( ( Suspected ( gastric ( outlet ( obstruction/partial SBO ) ) ) ) ( due ( to ( SMA syndrome ) ) ) ) ( ( ( ( suggested ( on ( radiographic studies ) ) ) , ) ( although ( ( duodenal ( narrowing ( not ap ) ) ) ( -LSB- ( ** ( ( Location ** ) ( -RSB- ( ted ( on ( repeat EGD ) ) ) ) ) ) ) ) ) ) . ) )

( ( The patient ) ( ( has ( had ( recent ( weight loss ) ) ) ) . ) )

23ef88c0-66c7-11e7-b08d-f45c89b91419

entailment

A CXR was performed and was c/w PNA.

There is an opacity on the chest X-ray.

(ROOT (S (NP (DT A) (NN CXR)) (VP (VP (VBD was) (VP (VBN performed))) (CC and) (VP (VBD was) (NP (JJ c/w) (NN PNA)))) (. .)))

(ROOT (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT an) (NN opacity)) (PP (IN on) (NP (DT the) (NN chest) (NN X-ray))))) (. .)))

( ( A CXR ) ( ( ( ( was performed ) and ) ( was ( c/w PNA ) ) ) . ) )

( There ( ( is ( ( an opacity ) ( on ( the ( chest X-ray ) ) ) ) ) . ) )

23ef8a78-66c7-11e7-a59c-f45c89b91419

contradiction

A CXR was performed and was c/w PNA.

The x-ray was clear.

(ROOT (S (NP (DT A) (NN CXR)) (VP (VP (VBD was) (VP (VBN performed))) (CC and) (VP (VBD was) (NP (JJ c/w) (NN PNA)))) (. .)))

(ROOT (S (NP (DT The) (NN x-ray)) (VP (VBD was) (ADJP (JJ clear))) (. .)))

( ( A CXR ) ( ( ( ( was performed ) and ) ( was ( c/w PNA ) ) ) . ) )

( ( The x-ray ) ( ( was clear ) . ) )

23ef8c08-66c7-11e7-8862-f45c89b91419

neutral

A CXR was performed and was c/w PNA.

The patient has a lobar pneumonia.

(ROOT (S (NP (DT A) (NN CXR)) (VP (VP (VBD was) (VP (VBN performed))) (CC and) (VP (VBD was) (NP (JJ c/w) (NN PNA)))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (DT a) (JJ lobar) (NN pneumonia))) (. .)))

( ( A CXR ) ( ( ( ( was performed ) and ) ( was ( c/w PNA ) ) ) . ) )

( ( The patient ) ( ( has ( a ( lobar pneumonia ) ) ) . ) )

23ef8f0a-66c7-11e7-9ec2-f45c89b91419

entailment

Initially, the pt did well overnight in the PACU on SIMV. - [**3-10**], he became tachypnic when his sedation was decreased.

The patient’s respiratory was high when sedation was decreased

(ROOT (S (ADVP (RB Initially)) (, ,) (S (NP (DT the) (NN pt)) (VP (VBD did) (NP (ADJP (ADJP (RB well) (JJ overnight) (PP (IN in) (NP (NP (DT the) (NNP PACU)) (PP (IN on) (NP (NNP SIMV)))))) (. .)) (: -) (PRN (-LRB- -LSB-) (WHADJP (SYM **) (QP (CD 3-10)) (X (SYM **))) (-RRB- -RSB-))))) (, ,) (NP (PRP he)) (VP (VBD became) (ADJP (JJ tachypnic)) (SBAR (WHADVP (WRB when)) (S (NP (PRP$ his) (NN sedation)) (VP (VBD was) (VP (VBN decreased)))))) (. .)))

(ROOT (S (NP (NP (DT The) (NN patient) (POS 's)) (NN respiratory)) (VP (VBD was) (ADJP (JJ high)) (SBAR (WHADVP (WRB when)) (S (NP (NN sedation)) (VP (VBD was) (VP (VBN decreased))))))))

( Initially ( , ( ( ( the pt ) ( did ( ( ( well ( overnight ( in ( ( the PACU ) ( on SIMV ) ) ) ) ) . ) ( - ( -LSB- ( ( ( ** 3-10 ) ** ) -RSB- ) ) ) ) ) ) ( , ( he ( ( ( became tachypnic ) ( when ( ( his sedation ) ( was decreased ) ) ) ) . ) ) ) ) ) )

( ( ( The ( patient 's ) ) respiratory ) ( ( was high ) ( when ( sedation ( was decreased ) ) ) ) )

23ef9162-66c7-11e7-9b84-f45c89b91419

contradiction

Initially, the pt did well overnight in the PACU on SIMV. - [**3-10**], he became tachypnic when his sedation was decreased.

The patient’s breathing was normal when sedation was decreased

(ROOT (S (ADVP (RB Initially)) (, ,) (S (NP (DT the) (NN pt)) (VP (VBD did) (NP (ADJP (ADJP (RB well) (JJ overnight) (PP (IN in) (NP (NP (DT the) (NNP PACU)) (PP (IN on) (NP (NNP SIMV)))))) (. .)) (: -) (PRN (-LRB- -LSB-) (WHADJP (SYM **) (QP (CD 3-10)) (X (SYM **))) (-RRB- -RSB-))))) (, ,) (NP (PRP he)) (VP (VBD became) (ADJP (JJ tachypnic)) (SBAR (WHADVP (WRB when)) (S (NP (PRP$ his) (NN sedation)) (VP (VBD was) (VP (VBN decreased)))))) (. .)))

(ROOT (S (NP (NP (DT The) (NN patient) (POS 's)) (NN breathing)) (VP (VBD was) (ADJP (JJ normal)) (SBAR (WHADVP (WRB when)) (S (NP (NN sedation)) (VP (VBD was) (VP (VBN decreased))))))))

( Initially ( , ( ( ( the pt ) ( did ( ( ( well ( overnight ( in ( ( the PACU ) ( on SIMV ) ) ) ) ) . ) ( - ( -LSB- ( ( ( ** 3-10 ) ** ) -RSB- ) ) ) ) ) ) ( , ( he ( ( ( became tachypnic ) ( when ( ( his sedation ) ( was decreased ) ) ) ) . ) ) ) ) ) )

( ( ( The ( patient 's ) ) breathing ) ( ( was normal ) ( when ( sedation ( was decreased ) ) ) ) )

23ef9400-66c7-11e7-b365-f45c89b91419

neutral

Initially, the pt did well overnight in the PACU on SIMV. - [**3-10**], he became tachypnic when his sedation was decreased.

The patient became agitated when sedation was decreased

(ROOT (S (ADVP (RB Initially)) (, ,) (S (NP (DT the) (NN pt)) (VP (VBD did) (NP (ADJP (ADJP (RB well) (JJ overnight) (PP (IN in) (NP (NP (DT the) (NNP PACU)) (PP (IN on) (NP (NNP SIMV)))))) (. .)) (: -) (PRN (-LRB- -LSB-) (WHADJP (SYM **) (QP (CD 3-10)) (X (SYM **))) (-RRB- -RSB-))))) (, ,) (NP (PRP he)) (VP (VBD became) (ADJP (JJ tachypnic)) (SBAR (WHADVP (WRB when)) (S (NP (PRP$ his) (NN sedation)) (VP (VBD was) (VP (VBN decreased)))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBD became) (VP (VBN agitated) (SBAR (WHADVP (WRB when)) (S (NP (NN sedation)) (VP (VBD was) (VP (VBN decreased)))))))))

( Initially ( , ( ( ( the pt ) ( did ( ( ( well ( overnight ( in ( ( the PACU ) ( on SIMV ) ) ) ) ) . ) ( - ( -LSB- ( ( ( ** 3-10 ) ** ) -RSB- ) ) ) ) ) ) ( , ( he ( ( ( became tachypnic ) ( when ( ( his sedation ) ( was decreased ) ) ) ) . ) ) ) ) ) )

( ( The patient ) ( became ( agitated ( when ( sedation ( was decreased ) ) ) ) ) )

23ef9978-66c7-11e7-bb84-f45c89b91419

entailment

He continued on the continuous positive airway pressure for an additional 48 hours and on day of life three was moved to room air.

The patient was recently born.

(ROOT (S (S (NP (PRP He)) (VP (VBD continued) (PP (PP (IN on) (NP (NP (DT the) (JJ continuous) (JJ positive) (NN airway) (NN pressure)) (PP (IN for) (NP (DT an) (JJ additional) (CD 48) (NNS hours))))) (CC and) (PP (IN on) (NP (NP (NN day)) (PP (IN of) (NP (NN life) (CD three))))))) (VP (VBD was) (VP (VBN moved) (PP (TO to) (NP (NN room) (NN air)))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBD was) (ADVP (RB recently)) (VP (VBN born))) (. .)))

( ( He ( ( continued ( ( ( on ( ( the ( continuous ( positive ( airway pressure ) ) ) ) ( for ( an ( additional ( 48 hours ) ) ) ) ) ) and ) ( on ( day ( of ( life three ) ) ) ) ) ) ( was ( moved ( to ( room air ) ) ) ) ) ) . )

( ( The patient ) ( ( ( was recently ) born ) . ) )

23ef9b9c-66c7-11e7-9a76-f45c89b91419

contradiction

He continued on the continuous positive airway pressure for an additional 48 hours and on day of life three was moved to room air.

The patient has normal lung function.

(ROOT (S (S (NP (PRP He)) (VP (VBD continued) (PP (PP (IN on) (NP (NP (DT the) (JJ continuous) (JJ positive) (NN airway) (NN pressure)) (PP (IN for) (NP (DT an) (JJ additional) (CD 48) (NNS hours))))) (CC and) (PP (IN on) (NP (NP (NN day)) (PP (IN of) (NP (NN life) (CD three))))))) (VP (VBD was) (VP (VBN moved) (PP (TO to) (NP (NN room) (NN air)))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (JJ normal) (NN lung) (NN function))) (. .)))

( ( He ( ( continued ( ( ( on ( ( the ( continuous ( positive ( airway pressure ) ) ) ) ( for ( an ( additional ( 48 hours ) ) ) ) ) ) and ) ( on ( day ( of ( life three ) ) ) ) ) ) ( was ( moved ( to ( room air ) ) ) ) ) ) . )

( ( The patient ) ( ( has ( normal ( lung function ) ) ) . ) )

23ef9f22-66c7-11e7-8476-f45c89b91419

neutral

He continued on the continuous positive airway pressure for an additional 48 hours and on day of life three was moved to room air.

The patient is on BiPAP.

(ROOT (S (S (NP (PRP He)) (VP (VBD continued) (PP (PP (IN on) (NP (NP (DT the) (JJ continuous) (JJ positive) (NN airway) (NN pressure)) (PP (IN for) (NP (DT an) (JJ additional) (CD 48) (NNS hours))))) (CC and) (PP (IN on) (NP (NP (NN day)) (PP (IN of) (NP (NN life) (CD three))))))) (VP (VBD was) (VP (VBN moved) (PP (TO to) (NP (NN room) (NN air)))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ is) (PP (IN on) (NP (NN BiPAP)))) (. .)))

( ( He ( ( continued ( ( ( on ( ( the ( continuous ( positive ( airway pressure ) ) ) ) ( for ( an ( additional ( 48 hours ) ) ) ) ) ) and ) ( on ( day ( of ( life three ) ) ) ) ) ) ( was ( moved ( to ( room air ) ) ) ) ) ) . )

( ( The patient ) ( ( is ( on BiPAP ) ) . ) )

23efa152-66c7-11e7-beaf-f45c89b91419

entailment

History of dilated ventricles first seen in [**3190**], but repeat MR in [**3191**], was unchanged.

The patient has dilated cardiomyopathy.

(ROOT (NP (NP (NP (NN History)) (PP (IN of) (NP (NP (JJ dilated) (NNS ventricles)) (VP (ADVP (RB first)) (VBN seen) (PP (IN in) (NP (QP (-LRB- -LSB-) (SYM **) (CD 3190) (X (SYM **)) (-RRB- -RSB-)))))))) (, ,) (CC but) (NP (NP (NN repeat) (NN MR)) (PP (IN in) (S (-LRB- -LSB-) (NP (SYM **) (CD 3191) (X (SYM **)) (-RRB- -RSB-)) (, ,) (VP (VBD was) (ADJP (JJ unchanged)))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (VP (VBN dilated) (NP (NN cardiomyopathy)))) (. .)))

( ( ( ( ( History ( of ( ( dilated ventricles ) ( first ( seen ( in ( -LSB- ( ** ( ( 3190 ** ) -RSB- ) ) ) ) ) ) ) ) ) , ) but ) ( ( repeat MR ) ( in ( -LSB- ( ( ** ( ( 3191 ** ) -RSB- ) ) ( , ( was unchanged ) ) ) ) ) ) ) . )

( ( The patient ) ( ( has ( dilated cardiomyopathy ) ) . ) )

23efa3be-66c7-11e7-a4a7-f45c89b91419

contradiction

History of dilated ventricles first seen in [**3190**], but repeat MR in [**3191**], was unchanged.

The patient has a normal heart.

(ROOT (NP (NP (NP (NN History)) (PP (IN of) (NP (NP (JJ dilated) (NNS ventricles)) (VP (ADVP (RB first)) (VBN seen) (PP (IN in) (NP (QP (-LRB- -LSB-) (SYM **) (CD 3190) (X (SYM **)) (-RRB- -RSB-)))))))) (, ,) (CC but) (NP (NP (NN repeat) (NN MR)) (PP (IN in) (S (-LRB- -LSB-) (NP (SYM **) (CD 3191) (X (SYM **)) (-RRB- -RSB-)) (, ,) (VP (VBD was) (ADJP (JJ unchanged)))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (DT a) (JJ normal) (NN heart))) (. .)))

( ( ( ( ( History ( of ( ( dilated ventricles ) ( first ( seen ( in ( -LSB- ( ** ( ( 3190 ** ) -RSB- ) ) ) ) ) ) ) ) ) , ) but ) ( ( repeat MR ) ( in ( -LSB- ( ( ** ( ( 3191 ** ) -RSB- ) ) ( , ( was unchanged ) ) ) ) ) ) ) . )

( ( The patient ) ( ( has ( a ( normal heart ) ) ) . ) )

23efa852-66c7-11e7-9b53-f45c89b91419

neutral

History of dilated ventricles first seen in [**3190**], but repeat MR in [**3191**], was unchanged.

The patient has ischemic cardiomyopathy.

(ROOT (NP (NP (NP (NN History)) (PP (IN of) (NP (NP (JJ dilated) (NNS ventricles)) (VP (ADVP (RB first)) (VBN seen) (PP (IN in) (NP (QP (-LRB- -LSB-) (SYM **) (CD 3190) (X (SYM **)) (-RRB- -RSB-)))))))) (, ,) (CC but) (NP (NP (NN repeat) (NN MR)) (PP (IN in) (S (-LRB- -LSB-) (NP (SYM **) (CD 3191) (X (SYM **)) (-RRB- -RSB-)) (, ,) (VP (VBD was) (ADJP (JJ unchanged)))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (JJ ischemic) (NN cardiomyopathy))) (. .)))

( ( ( ( ( History ( of ( ( dilated ventricles ) ( first ( seen ( in ( -LSB- ( ** ( ( 3190 ** ) -RSB- ) ) ) ) ) ) ) ) ) , ) but ) ( ( repeat MR ) ( in ( -LSB- ( ( ** ( ( 3191 ** ) -RSB- ) ) ( , ( was unchanged ) ) ) ) ) ) ) . )

( ( The patient ) ( ( has ( ischemic cardiomyopathy ) ) . ) )

23efabc0-66c7-11e7-b651-f45c89b91419

entailment

Coronary artery disease, status post non-ST elevation MI in [**2951**].

The patient has congestive heart failure.

(ROOT (NP (NP (NP (JJ Coronary) (NN artery) (NN disease)) (, ,) (NP (NP (NN status) (NN post) (JJ non-ST) (NN elevation) (NNP MI)) (PP (IN in) (PRN (-LRB- -LSB-) (FRAG (SYM **) (QP (CD 2951)) (X (SYM **))) (-RRB- -RSB-))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (JJ congestive) (NN heart) (NN failure))) (. .)))

( ( ( ( Coronary ( artery disease ) ) , ) ( ( status ( post ( non-ST ( elevation MI ) ) ) ) ( in ( -LSB- ( ( ** ( 2951 ** ) ) -RSB- ) ) ) ) ) . )

( ( The patient ) ( ( has ( congestive ( heart failure ) ) ) . ) )

23efaf64-66c7-11e7-a260-f45c89b91419

contradiction

Coronary artery disease, status post non-ST elevation MI in [**2951**].

The patient’s coronary arteries are of normal caliber.

(ROOT (NP (NP (NP (JJ Coronary) (NN artery) (NN disease)) (, ,) (NP (NP (NN status) (NN post) (JJ non-ST) (NN elevation) (NNP MI)) (PP (IN in) (PRN (-LRB- -LSB-) (FRAG (SYM **) (QP (CD 2951)) (X (SYM **))) (-RRB- -RSB-))))) (. .)))

(ROOT (S (NP (NP (DT The) (NN patient) (POS 's)) (JJ coronary) (NNS arteries)) (VP (VBP are) (PP (IN of) (NP (JJ normal) (NN caliber)))) (. .)))

( ( ( ( Coronary ( artery disease ) ) , ) ( ( status ( post ( non-ST ( elevation MI ) ) ) ) ( in ( -LSB- ( ( ** ( 2951 ** ) ) -RSB- ) ) ) ) ) . )

( ( ( The ( patient 's ) ) ( coronary arteries ) ) ( ( are ( of ( normal caliber ) ) ) . ) )

23efb228-66c7-11e7-807e-f45c89b91419

neutral

Coronary artery disease, status post non-ST elevation MI in [**2951**].

The patient is on a statin, beta blocker and ace-inhibitor.

(ROOT (NP (NP (NP (JJ Coronary) (NN artery) (NN disease)) (, ,) (NP (NP (NN status) (NN post) (JJ non-ST) (NN elevation) (NNP MI)) (PP (IN in) (PRN (-LRB- -LSB-) (FRAG (SYM **) (QP (CD 2951)) (X (SYM **))) (-RRB- -RSB-))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ is) (PP (IN on) (NP (NP (DT a) (NN statin)) (, ,) (NP (NN beta) (NN blocker)) (CC and) (NP (NN ace-inhibitor))))) (. .)))

( ( ( ( Coronary ( artery disease ) ) , ) ( ( status ( post ( non-ST ( elevation MI ) ) ) ) ( in ( -LSB- ( ( ** ( 2951 ** ) ) -RSB- ) ) ) ) ) . )

( ( The patient ) ( ( is ( on ( ( ( ( ( a statin ) , ) ( beta blocker ) ) and ) ace-inhibitor ) ) ) . ) )

23efb464-66c7-11e7-a143-f45c89b91419

entailment

She had elevated BNP (30,000) and troponin (0.09 - higher than baseline).

The patient has signs of a heart failure exacerbation.

(ROOT (S (NP (PRP She)) (VP (VBD had) (NP (NP (NP (JJ elevated) (NN BNP)) (PRN (-LRB- -LRB-) (NP (CD 30,000)) (-RRB- -RRB-))) (CC and) (NP (NP (NN troponin)) (PRN (-LRB- -LRB-) (FRAG (CD 0.09) (: -) (ADJP (ADJP (JJR higher)) (PP (IN than) (NP (NN baseline))))) (-RRB- -RRB-))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NP (NNS signs)) (PP (IN of) (NP (DT a) (NN heart) (NN failure) (NN exacerbation))))) (. .)))

( She ( ( had ( ( ( ( elevated BNP ) ( -LRB- ( 30,000 -RRB- ) ) ) and ) ( troponin ( -LRB- ( ( 0.09 ( - ( higher ( than baseline ) ) ) ) -RRB- ) ) ) ) ) . ) )

( ( The patient ) ( ( has ( signs ( of ( a ( heart ( failure exacerbation ) ) ) ) ) ) . ) )

23efb886-66c7-11e7-a273-f45c89b91419

contradiction

She had elevated BNP (30,000) and troponin (0.09 - higher than baseline).

The patient has a normal heart.

(ROOT (S (NP (PRP She)) (VP (VBD had) (NP (NP (NP (JJ elevated) (NN BNP)) (PRN (-LRB- -LRB-) (NP (CD 30,000)) (-RRB- -RRB-))) (CC and) (NP (NP (NN troponin)) (PRN (-LRB- -LRB-) (FRAG (CD 0.09) (: -) (ADJP (ADJP (JJR higher)) (PP (IN than) (NP (NN baseline))))) (-RRB- -RRB-))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (DT a) (JJ normal) (NN heart))) (. .)))

( She ( ( had ( ( ( ( elevated BNP ) ( -LRB- ( 30,000 -RRB- ) ) ) and ) ( troponin ( -LRB- ( ( 0.09 ( - ( higher ( than baseline ) ) ) ) -RRB- ) ) ) ) ) . ) )

( ( The patient ) ( ( has ( a ( normal heart ) ) ) . ) )

23efbac8-66c7-11e7-9c45-f45c89b91419

neutral

She had elevated BNP (30,000) and troponin (0.09 - higher than baseline).

The patient has cardiac ischemia.

(ROOT (S (NP (PRP She)) (VP (VBD had) (NP (NP (NP (JJ elevated) (NN BNP)) (PRN (-LRB- -LRB-) (NP (CD 30,000)) (-RRB- -RRB-))) (CC and) (NP (NP (NN troponin)) (PRN (-LRB- -LRB-) (FRAG (CD 0.09) (: -) (ADJP (ADJP (JJR higher)) (PP (IN than) (NP (NN baseline))))) (-RRB- -RRB-))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (JJ cardiac) (NN ischemia))) (. .)))

( She ( ( had ( ( ( ( elevated BNP ) ( -LRB- ( 30,000 -RRB- ) ) ) and ) ( troponin ( -LRB- ( ( 0.09 ( - ( higher ( than baseline ) ) ) ) -RRB- ) ) ) ) ) . ) )

( ( The patient ) ( ( has ( cardiac ischemia ) ) . ) )

23efbca2-66c7-11e7-bf3e-f45c89b91419

entailment

All of the other review of systems were negative. .

Patient reports no pain

(ROOT (S (NP (NP (DT All)) (PP (IN of) (NP (NP (DT the) (JJ other) (NN review)) (PP (IN of) (NP (NNS systems)))))) (VP (VBD were) (ADJP (JJ negative))) (. .) (. .)))

(ROOT (NP (NP (NN Patient) (NNS reports)) (NP (DT no) (NN pain))))

( ( All ( of ( ( the ( other review ) ) ( of systems ) ) ) ) ( ( ( were negative ) . ) . ) )

( ( Patient reports ) ( no pain ) )

23efbe50-66c7-11e7-9909-f45c89b91419

contradiction

All of the other review of systems were negative. .

The patient reports abdominal pain

(ROOT (S (NP (NP (DT All)) (PP (IN of) (NP (NP (DT the) (JJ other) (NN review)) (PP (IN of) (NP (NNS systems)))))) (VP (VBD were) (ADJP (JJ negative))) (. .) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (NNS reports) (NP (JJ abdominal) (NN pain)))))

( ( All ( of ( ( the ( other review ) ) ( of systems ) ) ) ) ( ( ( were negative ) . ) . ) )

( ( The patient ) ( reports ( abdominal pain ) ) )

23efc05e-66c7-11e7-ae12-f45c89b91419

neutral

All of the other review of systems were negative. .

Patient has no past medical history

(ROOT (S (NP (NP (DT All)) (PP (IN of) (NP (NP (DT the) (JJ other) (NN review)) (PP (IN of) (NP (NNS systems)))))) (VP (VBD were) (ADJP (JJ negative))) (. .) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (DT no) (JJ past) (JJ medical) (NN history)))))

( ( All ( of ( ( the ( other review ) ) ( of systems ) ) ) ) ( ( ( were negative ) . ) . ) )

( Patient ( has ( no ( past ( medical history ) ) ) ) )

23efc350-66c7-11e7-875d-f45c89b91419

entailment

He reports doing well when he was on 60 mg --> down to 40 mg of prednisone, when he dropped dose to 30mg / day as a part of the taper, he started getting progressively worse in terms of breathing.

He is on a Prednisone taper

(ROOT (S (S (NP (PRP He)) (VP (VBZ reports) (NP (S (VP (VBG doing) (ADVP (RB well)) (SBAR (WHADVP (WRB when)) (S (NP (PRP he)) (VP (VBD was) (PP (IN on) (NP (NP (CD 60) (NN mg)) (: --) (NP (NP (QP (JJR >) (IN down) (TO to) (CD 40)) (NN mg)) (PP (IN of) (NP (NN prednisone)))) (, ,))) (SBAR (WHADVP (WRB when)) (S (NP (PRP he)) (VP (VBD dropped) (NP (NN dose)) (PP (TO to) (NP (CD 30mg))))))))))) (: /) (NN day)) (PP (IN as) (NP (NP (DT a) (NN part)) (PP (IN of) (NP (DT the) (VBP taper))))))) (, ,) (NP (PRP he)) (VP (VBD started) (S (VP (VBG getting) (ADJP (RB progressively) (JJR worse)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NN breathing)))))))) (. .)))

(ROOT (S (NP (PRP He)) (VP (VBZ is) (S (PP (IN on) (NP (DT a) (NN Prednisone))) (VP (VB taper))))))

( ( He ( ( reports ( ( ( doing well ) ( when ( he ( ( was ( on ( ( ( ( 60 mg ) -- ) ( ( ( > ( ( down to ) 40 ) ) mg ) ( of prednisone ) ) ) , ) ) ) ( when ( he ( ( dropped dose ) ( to 30mg ) ) ) ) ) ) ) ) ( / day ) ) ) ( as ( ( a part ) ( of ( the taper ) ) ) ) ) ) ( , ( he ( ( started ( ( getting ( progressively worse ) ) ( in ( terms ( of breathing ) ) ) ) ) . ) ) ) )

( He ( is ( ( on ( a Prednisone ) ) taper ) ) )

23efc8b4-66c7-11e7-8de7-f45c89b91419

contradiction

He reports doing well when he was on 60 mg --> down to 40 mg of prednisone, when he dropped dose to 30mg / day as a part of the taper, he started getting progressively worse in terms of breathing.

HE has no shortness of breath

(ROOT (S (S (NP (PRP He)) (VP (VBZ reports) (NP (S (VP (VBG doing) (ADVP (RB well)) (SBAR (WHADVP (WRB when)) (S (NP (PRP he)) (VP (VBD was) (PP (IN on) (NP (NP (CD 60) (NN mg)) (: --) (NP (NP (QP (JJR >) (IN down) (TO to) (CD 40)) (NN mg)) (PP (IN of) (NP (NN prednisone)))) (, ,))) (SBAR (WHADVP (WRB when)) (S (NP (PRP he)) (VP (VBD dropped) (NP (NN dose)) (PP (TO to) (NP (CD 30mg))))))))))) (: /) (NN day)) (PP (IN as) (NP (NP (DT a) (NN part)) (PP (IN of) (NP (DT the) (VBP taper))))))) (, ,) (NP (PRP he)) (VP (VBD started) (S (VP (VBG getting) (ADJP (RB progressively) (JJR worse)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NN breathing)))))))) (. .)))

(ROOT (S (NP (PRP HE)) (VP (VBZ has) (NP (NP (DT no) (NN shortness)) (PP (IN of) (NP (NN breath)))))))

( ( He ( ( reports ( ( ( doing well ) ( when ( he ( ( was ( on ( ( ( ( 60 mg ) -- ) ( ( ( > ( ( down to ) 40 ) ) mg ) ( of prednisone ) ) ) , ) ) ) ( when ( he ( ( dropped dose ) ( to 30mg ) ) ) ) ) ) ) ) ( / day ) ) ) ( as ( ( a part ) ( of ( the taper ) ) ) ) ) ) ( , ( he ( ( started ( ( getting ( progressively worse ) ) ( in ( terms ( of breathing ) ) ) ) ) . ) ) ) )

( HE ( has ( ( no shortness ) ( of breath ) ) ) )

23efcda6-66c7-11e7-b585-f45c89b91419

neutral

He reports doing well when he was on 60 mg --> down to 40 mg of prednisone, when he dropped dose to 30mg / day as a part of the taper, he started getting progressively worse in terms of breathing.

HE is being treated for lung disease

(ROOT (S (S (NP (PRP He)) (VP (VBZ reports) (NP (S (VP (VBG doing) (ADVP (RB well)) (SBAR (WHADVP (WRB when)) (S (NP (PRP he)) (VP (VBD was) (PP (IN on) (NP (NP (CD 60) (NN mg)) (: --) (NP (NP (QP (JJR >) (IN down) (TO to) (CD 40)) (NN mg)) (PP (IN of) (NP (NN prednisone)))) (, ,))) (SBAR (WHADVP (WRB when)) (S (NP (PRP he)) (VP (VBD dropped) (NP (NN dose)) (PP (TO to) (NP (CD 30mg))))))))))) (: /) (NN day)) (PP (IN as) (NP (NP (DT a) (NN part)) (PP (IN of) (NP (DT the) (VBP taper))))))) (, ,) (NP (PRP he)) (VP (VBD started) (S (VP (VBG getting) (ADJP (RB progressively) (JJR worse)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NN breathing)))))))) (. .)))

(ROOT (S (NP (PRP HE)) (VP (VBZ is) (VP (VBG being) (VP (VBN treated) (PP (IN for) (NP (NN lung) (NN disease))))))))

( ( He ( ( reports ( ( ( doing well ) ( when ( he ( ( was ( on ( ( ( ( 60 mg ) -- ) ( ( ( > ( ( down to ) 40 ) ) mg ) ( of prednisone ) ) ) , ) ) ) ( when ( he ( ( dropped dose ) ( to 30mg ) ) ) ) ) ) ) ) ( / day ) ) ) ( as ( ( a part ) ( of ( the taper ) ) ) ) ) ) ( , ( he ( ( started ( ( getting ( progressively worse ) ) ( in ( terms ( of breathing ) ) ) ) ) . ) ) ) )

( HE ( is ( being ( treated ( for ( lung disease ) ) ) ) ) )

23efd1ae-66c7-11e7-bdc1-f45c89b91419

entailment

No recent weight loss, fever, chills, diarrhea, vomiting, nausea, abdominal pain.

The patient does not have symptoms of gastroenteritis.

(ROOT (NP (NP (NP (DT No) (JJ recent) (NN weight) (NN loss)) (, ,) (NP (NN fever)) (, ,) (NP (NNS chills)) (, ,) (NP (NN diarrhea)) (, ,) (NP (VBG vomiting) (, ,) (NN nausea) (, ,) (JJ abdominal) (NN pain))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ does) (RB not) (VP (VB have) (NP (NP (NNS symptoms)) (PP (IN of) (NP (NN gastroenteritis)))))) (. .)))

( ( ( ( ( ( ( ( ( ( No ( recent ( weight loss ) ) ) , ) fever ) , ) chills ) , ) diarrhea ) , ) ( vomiting ( , ( nausea ( , ( abdominal pain ) ) ) ) ) ) . )

( ( The patient ) ( ( ( does not ) ( have ( symptoms ( of gastroenteritis ) ) ) ) . ) )

23efd3f4-66c7-11e7-9111-f45c89b91419

contradiction

No recent weight loss, fever, chills, diarrhea, vomiting, nausea, abdominal pain.

The patient a serious clostridium difficile infection.

(ROOT (NP (NP (NP (DT No) (JJ recent) (NN weight) (NN loss)) (, ,) (NP (NN fever)) (, ,) (NP (NNS chills)) (, ,) (NP (NN diarrhea)) (, ,) (NP (VBG vomiting) (, ,) (NN nausea) (, ,) (JJ abdominal) (NN pain))) (. .)))

(ROOT (NP (NP (NP (DT The) (NN patient)) (NP (DT a) (JJ serious) (NN clostridium) (NN difficile) (NN infection))) (. .)))

( ( ( ( ( ( ( ( ( ( No ( recent ( weight loss ) ) ) , ) fever ) , ) chills ) , ) diarrhea ) , ) ( vomiting ( , ( nausea ( , ( abdominal pain ) ) ) ) ) ) . )

( ( ( The patient ) ( a ( serious ( clostridium ( difficile infection ) ) ) ) ) . )

23efd5dc-66c7-11e7-aeb5-f45c89b91419

neutral

No recent weight loss, fever, chills, diarrhea, vomiting, nausea, abdominal pain.

The patient does have a gastrointestinal infection.

(ROOT (NP (NP (NP (DT No) (JJ recent) (NN weight) (NN loss)) (, ,) (NP (NN fever)) (, ,) (NP (NNS chills)) (, ,) (NP (NN diarrhea)) (, ,) (NP (VBG vomiting) (, ,) (NN nausea) (, ,) (JJ abdominal) (NN pain))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ does) (VP (VB have) (NP (DT a) (JJ gastrointestinal) (NN infection)))) (. .)))

( ( ( ( ( ( ( ( ( ( No ( recent ( weight loss ) ) ) , ) fever ) , ) chills ) , ) diarrhea ) , ) ( vomiting ( , ( nausea ( , ( abdominal pain ) ) ) ) ) ) . )

( ( The patient ) ( ( does ( have ( a ( gastrointestinal infection ) ) ) ) . ) )

23efd7ee-66c7-11e7-bd32-f45c89b91419

entailment

His symptoms started a month ago with jaundice and weight loss and he was found to have an ampullary adenoma on endoscopy but it was too big for resection.

Patient has a benign growth

(ROOT (S (S (NP (PRP$ His) (NNS symptoms)) (VP (VBD started) (ADVP (NP (DT a) (NN month)) (RB ago)) (PP (IN with) (NP (NP (NN jaundice)) (CC and) (NP (NN weight) (NN loss)))))) (CC and) (S (NP (PRP he)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB have) (NP (NP (DT an) (JJ ampullary) (NN adenoma)) (PP (IN on) (NP (NN endoscopy)))))))))) (CC but) (S (NP (PRP it)) (VP (VBD was) (ADJP (RB too) (JJ big) (PP (IN for) (NP (NN resection)))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (DT a) (JJ benign) (NN growth)))))

( ( ( ( ( ( ( His symptoms ) ( ( started ( ( a month ) ago ) ) ( with ( ( jaundice and ) ( weight loss ) ) ) ) ) and ) ( he ( was ( found ( to ( have ( ( an ( ampullary adenoma ) ) ( on endoscopy ) ) ) ) ) ) ) ) but ) ( it ( was ( too ( big ( for resection ) ) ) ) ) ) . )

( Patient ( has ( a ( benign growth ) ) ) )

23efda1c-66c7-11e7-980a-f45c89b91419

contradiction

His symptoms started a month ago with jaundice and weight loss and he was found to have an ampullary adenoma on endoscopy but it was too big for resection.

Patient has no symptoms

(ROOT (S (S (NP (PRP$ His) (NNS symptoms)) (VP (VBD started) (ADVP (NP (DT a) (NN month)) (RB ago)) (PP (IN with) (NP (NP (NN jaundice)) (CC and) (NP (NN weight) (NN loss)))))) (CC and) (S (NP (PRP he)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB have) (NP (NP (DT an) (JJ ampullary) (NN adenoma)) (PP (IN on) (NP (NN endoscopy)))))))))) (CC but) (S (NP (PRP it)) (VP (VBD was) (ADJP (RB too) (JJ big) (PP (IN for) (NP (NN resection)))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (DT no) (NNS symptoms)))))

( ( ( ( ( ( ( His symptoms ) ( ( started ( ( a month ) ago ) ) ( with ( ( jaundice and ) ( weight loss ) ) ) ) ) and ) ( he ( was ( found ( to ( have ( ( an ( ampullary adenoma ) ) ( on endoscopy ) ) ) ) ) ) ) ) but ) ( it ( was ( too ( big ( for resection ) ) ) ) ) ) . )

( Patient ( has ( no symptoms ) ) )

23efdc3a-66c7-11e7-828d-f45c89b91419

neutral

His symptoms started a month ago with jaundice and weight loss and he was found to have an ampullary adenoma on endoscopy but it was too big for resection.

Patient has had ERCP

(ROOT (S (S (NP (PRP$ His) (NNS symptoms)) (VP (VBD started) (ADVP (NP (DT a) (NN month)) (RB ago)) (PP (IN with) (NP (NP (NN jaundice)) (CC and) (NP (NN weight) (NN loss)))))) (CC and) (S (NP (PRP he)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB have) (NP (NP (DT an) (JJ ampullary) (NN adenoma)) (PP (IN on) (NP (NN endoscopy)))))))))) (CC but) (S (NP (PRP it)) (VP (VBD was) (ADJP (RB too) (JJ big) (PP (IN for) (NP (NN resection)))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (VP (VBN had) (NP (NNS ERCP))))))

( ( ( ( ( ( ( His symptoms ) ( ( started ( ( a month ) ago ) ) ( with ( ( jaundice and ) ( weight loss ) ) ) ) ) and ) ( he ( was ( found ( to ( have ( ( an ( ampullary adenoma ) ) ( on endoscopy ) ) ) ) ) ) ) ) but ) ( it ( was ( too ( big ( for resection ) ) ) ) ) ) . )

( Patient ( has ( had ERCP ) ) )

23efded0-66c7-11e7-a193-f45c89b91419

entailment

She was moving all extremities to noxious stimulation.

She has some neurological function

(ROOT (S (NP (PRP She)) (VP (VBD was) (VP (VBG moving) (NP (DT all) (NNS extremities)) (PP (TO to) (NP (JJ noxious) (NN stimulation))))) (. .)))

(ROOT (S (NP (PRP She)) (VP (VBZ has) (NP (DT some) (JJ neurological) (NN function)))))

( She ( ( was ( ( moving ( all extremities ) ) ( to ( noxious stimulation ) ) ) ) . ) )

( She ( has ( some ( neurological function ) ) ) )

23efe450-66c7-11e7-890f-f45c89b91419

contradiction

She was moving all extremities to noxious stimulation.

She is unresponsive

(ROOT (S (NP (PRP She)) (VP (VBD was) (VP (VBG moving) (NP (DT all) (NNS extremities)) (PP (TO to) (NP (JJ noxious) (NN stimulation))))) (. .)))

(ROOT (S (NP (PRP She)) (VP (VBZ is) (ADJP (JJ unresponsive)))))

( She ( ( was ( ( moving ( all extremities ) ) ( to ( noxious stimulation ) ) ) ) . ) )

( She ( is unresponsive ) )

23efe748-66c7-11e7-9789-f45c89b91419

neutral

She was moving all extremities to noxious stimulation.

She is unconscious

(ROOT (S (NP (PRP She)) (VP (VBD was) (VP (VBG moving) (NP (DT all) (NNS extremities)) (PP (TO to) (NP (JJ noxious) (NN stimulation))))) (. .)))

(ROOT (S (NP (PRP She)) (VP (VBZ is) (ADJP (JJ unconscious)))))

( She ( ( was ( ( moving ( all extremities ) ) ( to ( noxious stimulation ) ) ) ) . ) )

( She ( is unconscious ) )

23efe950-66c7-11e7-a93a-f45c89b91419

entailment

Patient was transferred back to Medicine on [**5-31**] for further work-up of his coronary disease.

Patient has heart disease

(ROOT (S (NP (NN Patient)) (VP (VBD was) (VP (VBN transferred) (ADVP (RB back) (PP (TO to) (NP (NN Medicine)))) (PP (IN on) (NP (-LRB- -LSB-) (SYM **) (CD 5-31) (X (X (SYM **)) (-RRB- -RSB-) (PP (IN for) (NP (NP (JJ further) (NN work-up)) (PP (IN of) (NP (PRP$ his) (JJ coronary) (NN disease)))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (NN heart) (NN disease)))))

( Patient ( ( was ( ( transferred ( back ( to Medicine ) ) ) ( on ( -LSB- ( ** ( 5-31 ( ** ( -RSB- ( for ( ( further work-up ) ( of ( his ( coronary disease ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )

( Patient ( has ( heart disease ) ) )

23efeb26-66c7-11e7-b431-f45c89b91419

contradiction

Patient was transferred back to Medicine on [**5-31**] for further work-up of his coronary disease.

Normal cardiac function

(ROOT (S (NP (NN Patient)) (VP (VBD was) (VP (VBN transferred) (ADVP (RB back) (PP (TO to) (NP (NN Medicine)))) (PP (IN on) (NP (-LRB- -LSB-) (SYM **) (CD 5-31) (X (X (SYM **)) (-RRB- -RSB-) (PP (IN for) (NP (NP (JJ further) (NN work-up)) (PP (IN of) (NP (PRP$ his) (JJ coronary) (NN disease)))))))))) (. .)))

(ROOT (NP (JJ Normal) (JJ cardiac) (NN function)))

( Patient ( ( was ( ( transferred ( back ( to Medicine ) ) ) ( on ( -LSB- ( ** ( 5-31 ( ** ( -RSB- ( for ( ( further work-up ) ( of ( his ( coronary disease ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )

( Normal ( cardiac function ) )

23efed80-66c7-11e7-a098-f45c89b91419

neutral

Patient was transferred back to Medicine on [**5-31**] for further work-up of his coronary disease.

Patient has a history of myocardial infarction

(ROOT (S (NP (NN Patient)) (VP (VBD was) (VP (VBN transferred) (ADVP (RB back) (PP (TO to) (NP (NN Medicine)))) (PP (IN on) (NP (-LRB- -LSB-) (SYM **) (CD 5-31) (X (X (SYM **)) (-RRB- -RSB-) (PP (IN for) (NP (NP (JJ further) (NN work-up)) (PP (IN of) (NP (PRP$ his) (JJ coronary) (NN disease)))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (JJ myocardial) (NN infarction)))))))

( Patient ( ( was ( ( transferred ( back ( to Medicine ) ) ) ( on ( -LSB- ( ** ( 5-31 ( ** ( -RSB- ( for ( ( further work-up ) ( of ( his ( coronary disease ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )

( Patient ( has ( ( a history ) ( of ( myocardial infarction ) ) ) ) )

23efef5e-66c7-11e7-afc8-f45c89b91419

entailment

Prenatal screens: Blood type B negative, antibody negative, Rubella immune, RPR nonreactive, hepatitis B surface antigen negative, group Beta strep status negative.

Prenatal screens were negative

(ROOT (NP (NP (NP (JJ Prenatal) (NNS screens)) (: :) (NP (NP (UCP (ADJP (NP (NN Blood) (NN type) (NN B)) (JJ negative)) (, ,) (ADJP (ADJP (NN antibody) (JJ negative)) (, ,) (ADJP (JJ Rubella)) (ADJP (JJ immune) (, ,) (ADJP (NN RPR) (JJ nonreactive)) (, ,)))) (NN hepatitis) (NN B) (NN surface) (NN antigen) (JJ negative) (, ,) (NN group) (NN Beta) (JJ strep) (NN status)) (ADJP (JJ negative)))) (. .)))

(ROOT (S (NP (JJ Prenatal) (NNS screens)) (VP (VBD were) (ADJP (JJ negative)))))

( ( ( ( Prenatal screens ) : ) ( ( ( ( ( Blood ( type B ) ) negative ) ( , ( ( ( ( antibody negative ) , ) Rubella ) ( ( ( immune , ) ( RPR nonreactive ) ) , ) ) ) ) ( hepatitis ( B ( surface ( antigen ( negative ( , ( group ( Beta ( strep status ) ) ) ) ) ) ) ) ) ) negative ) ) . )

( ( Prenatal screens ) ( were negative ) )

23eff134-66c7-11e7-918c-f45c89b91419

contradiction

Prenatal screens: Blood type B negative, antibody negative, Rubella immune, RPR nonreactive, hepatitis B surface antigen negative, group Beta strep status negative.

Tested positive for group B strep

(ROOT (NP (NP (NP (JJ Prenatal) (NNS screens)) (: :) (NP (NP (UCP (ADJP (NP (NN Blood) (NN type) (NN B)) (JJ negative)) (, ,) (ADJP (ADJP (NN antibody) (JJ negative)) (, ,) (ADJP (JJ Rubella)) (ADJP (JJ immune) (, ,) (ADJP (NN RPR) (JJ nonreactive)) (, ,)))) (NN hepatitis) (NN B) (NN surface) (NN antigen) (JJ negative) (, ,) (NN group) (NN Beta) (JJ strep) (NN status)) (ADJP (JJ negative)))) (. .)))

(ROOT (S (VP (VBN Tested) (ADJP (ADJP (JJ positive) (PP (IN for) (NP (NN group) (NN B)))) (ADJP (NP (JJ strep)))))))

( ( ( ( Prenatal screens ) : ) ( ( ( ( ( Blood ( type B ) ) negative ) ( , ( ( ( ( antibody negative ) , ) Rubella ) ( ( ( immune , ) ( RPR nonreactive ) ) , ) ) ) ) ( hepatitis ( B ( surface ( antigen ( negative ( , ( group ( Beta ( strep status ) ) ) ) ) ) ) ) ) ) negative ) ) . )

( Tested ( ( positive ( for ( group B ) ) ) strep ) )

23eff300-66c7-11e7-a676-f45c89b91419

neutral

Prenatal screens: Blood type B negative, antibody negative, Rubella immune, RPR nonreactive, hepatitis B surface antigen negative, group Beta strep status negative.

No past medical history

(ROOT (NP (NP (NP (JJ Prenatal) (NNS screens)) (: :) (NP (NP (UCP (ADJP (NP (NN Blood) (NN type) (NN B)) (JJ negative)) (, ,) (ADJP (ADJP (NN antibody) (JJ negative)) (, ,) (ADJP (JJ Rubella)) (ADJP (JJ immune) (, ,) (ADJP (NN RPR) (JJ nonreactive)) (, ,)))) (NN hepatitis) (NN B) (NN surface) (NN antigen) (JJ negative) (, ,) (NN group) (NN Beta) (JJ strep) (NN status)) (ADJP (JJ negative)))) (. .)))

(ROOT (NP (DT No) (JJ past) (JJ medical) (NN history)))

( ( ( ( Prenatal screens ) : ) ( ( ( ( ( Blood ( type B ) ) negative ) ( , ( ( ( ( antibody negative ) , ) Rubella ) ( ( ( immune , ) ( RPR nonreactive ) ) , ) ) ) ) ( hepatitis ( B ( surface ( antigen ( negative ( , ( group ( Beta ( strep status ) ) ) ) ) ) ) ) ) ) negative ) ) . )

( No ( past ( medical history ) ) )

23eff622-66c7-11e7-b6e1-f45c89b91419

entailment

She had a cardiac catheterization which revealed 3-vessel disease with normal left main, mid left anterior descending artery 60%, diffuse 90% mid distal stenosis at the origin of the diagonal, serial 70% and 90% left circumflex lesions, and 90% first obtuse marginal, and mid right coronary artery 60%.

The patient has stenosis of the coronary arteries.

(ROOT (S (NP (PRP She)) (VP (VP (VBD had) (NP (NP (DT a) (JJ cardiac) (NN catheterization)) (SBAR (WHNP (WDT which)) (S (VP (VBD revealed) (NP (NP (JJ 3-vessel) (NN disease)) (PP (IN with) (ADJP (JJ normal) (SBAR (S (ADJP (ADJP (JJ left) (JJ main)) (, ,) (ADJP (JJ mid))) (VP (VBD left) (NP (ADJP (JJ anterior)) (VBG descending) (NN artery)) (SBAR (S (NP (NP (CD 60) (NN %)) (, ,) (NP (NP (NP (JJ diffuse)) (NP (ADJP (CD 90) (NN %)) (JJ mid) (JJ distal) (NN stenosis))) (PP (IN at) (NP (NP (DT the) (NN origin)) (PP (IN of) (NP (NP (DT the) (JJ diagonal) (, ,) (JJ serial) (CD 70) (NN %)) (CC and) (NP (CD 90) (NN %)))))))) (VP (VBD left) (NP (JJ circumflex) (NNS lesions)))))))))))))))) (, ,) (CC and) (VP (NP (CD 90) (NN %)) (S (NP (JJ first) (ADJP (ADJP (JJ obtuse) (JJ marginal)) (, ,) (CC and) (ADJP (JJ mid) (JJ right))) (JJ coronary) (NN artery)) (NP (CD 60) (NN %))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NP (NN stenosis)) (PP (IN of) (NP (DT the) (JJ coronary) (NNS arteries))))) (. .)))

( She ( ( ( ( ( had ( ( a ( cardiac catheterization ) ) ( which ( revealed ( ( 3-vessel disease ) ( with ( normal ( ( ( ( left main ) , ) mid ) ( ( left ( anterior ( descending artery ) ) ) ( ( ( ( 60 % ) , ) ( ( diffuse ( ( 90 % ) ( mid ( distal stenosis ) ) ) ) ( at ( ( the origin ) ( of ( ( ( the ( diagonal ( , ( serial ( 70 % ) ) ) ) ) and ) ( 90 % ) ) ) ) ) ) ) ( left ( circumflex lesions ) ) ) ) ) ) ) ) ) ) ) ) , ) and ) ( ( 90 % ) ( ( first ( ( ( ( ( obtuse marginal ) , ) and ) ( mid right ) ) ( coronary artery ) ) ) ( 60 % ) ) ) ) . ) )

( ( The patient ) ( ( has ( stenosis ( of ( the ( coronary arteries ) ) ) ) ) . ) )

23effa80-66c7-11e7-acf5-f45c89b91419

contradiction

She had a cardiac catheterization which revealed 3-vessel disease with normal left main, mid left anterior descending artery 60%, diffuse 90% mid distal stenosis at the origin of the diagonal, serial 70% and 90% left circumflex lesions, and 90% first obtuse marginal, and mid right coronary artery 60%.

The patient has normal coronary arteries.

(ROOT (S (NP (PRP She)) (VP (VP (VBD had) (NP (NP (DT a) (JJ cardiac) (NN catheterization)) (SBAR (WHNP (WDT which)) (S (VP (VBD revealed) (NP (NP (JJ 3-vessel) (NN disease)) (PP (IN with) (ADJP (JJ normal) (SBAR (S (ADJP (ADJP (JJ left) (JJ main)) (, ,) (ADJP (JJ mid))) (VP (VBD left) (NP (ADJP (JJ anterior)) (VBG descending) (NN artery)) (SBAR (S (NP (NP (CD 60) (NN %)) (, ,) (NP (NP (NP (JJ diffuse)) (NP (ADJP (CD 90) (NN %)) (JJ mid) (JJ distal) (NN stenosis))) (PP (IN at) (NP (NP (DT the) (NN origin)) (PP (IN of) (NP (NP (DT the) (JJ diagonal) (, ,) (JJ serial) (CD 70) (NN %)) (CC and) (NP (CD 90) (NN %)))))))) (VP (VBD left) (NP (JJ circumflex) (NNS lesions)))))))))))))))) (, ,) (CC and) (VP (NP (CD 90) (NN %)) (S (NP (JJ first) (ADJP (ADJP (JJ obtuse) (JJ marginal)) (, ,) (CC and) (ADJP (JJ mid) (JJ right))) (JJ coronary) (NN artery)) (NP (CD 60) (NN %))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (JJ normal) (JJ coronary) (NNS arteries))) (. .)))

( She ( ( ( ( ( had ( ( a ( cardiac catheterization ) ) ( which ( revealed ( ( 3-vessel disease ) ( with ( normal ( ( ( ( left main ) , ) mid ) ( ( left ( anterior ( descending artery ) ) ) ( ( ( ( 60 % ) , ) ( ( diffuse ( ( 90 % ) ( mid ( distal stenosis ) ) ) ) ( at ( ( the origin ) ( of ( ( ( the ( diagonal ( , ( serial ( 70 % ) ) ) ) ) and ) ( 90 % ) ) ) ) ) ) ) ( left ( circumflex lesions ) ) ) ) ) ) ) ) ) ) ) ) , ) and ) ( ( 90 % ) ( ( first ( ( ( ( ( obtuse marginal ) , ) and ) ( mid right ) ) ( coronary artery ) ) ) ( 60 % ) ) ) ) . ) )

( ( The patient ) ( ( has ( normal ( coronary arteries ) ) ) . ) )

23effdfa-66c7-11e7-8c3e-f45c89b91419

neutral

She had a cardiac catheterization which revealed 3-vessel disease with normal left main, mid left anterior descending artery 60%, diffuse 90% mid distal stenosis at the origin of the diagonal, serial 70% and 90% left circumflex lesions, and 90% first obtuse marginal, and mid right coronary artery 60%.

The patient would benefit from coronary artery bypass grafting.

(ROOT (S (NP (PRP She)) (VP (VP (VBD had) (NP (NP (DT a) (JJ cardiac) (NN catheterization)) (SBAR (WHNP (WDT which)) (S (VP (VBD revealed) (NP (NP (JJ 3-vessel) (NN disease)) (PP (IN with) (ADJP (JJ normal) (SBAR (S (ADJP (ADJP (JJ left) (JJ main)) (, ,) (ADJP (JJ mid))) (VP (VBD left) (NP (ADJP (JJ anterior)) (VBG descending) (NN artery)) (SBAR (S (NP (NP (CD 60) (NN %)) (, ,) (NP (NP (NP (JJ diffuse)) (NP (ADJP (CD 90) (NN %)) (JJ mid) (JJ distal) (NN stenosis))) (PP (IN at) (NP (NP (DT the) (NN origin)) (PP (IN of) (NP (NP (DT the) (JJ diagonal) (, ,) (JJ serial) (CD 70) (NN %)) (CC and) (NP (CD 90) (NN %)))))))) (VP (VBD left) (NP (JJ circumflex) (NNS lesions)))))))))))))))) (, ,) (CC and) (VP (NP (CD 90) (NN %)) (S (NP (JJ first) (ADJP (ADJP (JJ obtuse) (JJ marginal)) (, ,) (CC and) (ADJP (JJ mid) (JJ right))) (JJ coronary) (NN artery)) (NP (CD 60) (NN %))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (MD would) (VP (VB benefit) (PP (IN from) (NP (JJ coronary) (NN artery) (NN bypass) (NN grafting))))) (. .)))

( She ( ( ( ( ( had ( ( a ( cardiac catheterization ) ) ( which ( revealed ( ( 3-vessel disease ) ( with ( normal ( ( ( ( left main ) , ) mid ) ( ( left ( anterior ( descending artery ) ) ) ( ( ( ( 60 % ) , ) ( ( diffuse ( ( 90 % ) ( mid ( distal stenosis ) ) ) ) ( at ( ( the origin ) ( of ( ( ( the ( diagonal ( , ( serial ( 70 % ) ) ) ) ) and ) ( 90 % ) ) ) ) ) ) ) ( left ( circumflex lesions ) ) ) ) ) ) ) ) ) ) ) ) , ) and ) ( ( 90 % ) ( ( first ( ( ( ( ( obtuse marginal ) , ) and ) ( mid right ) ) ( coronary artery ) ) ) ( 60 % ) ) ) ) . ) )

( ( The patient ) ( ( would ( benefit ( from ( coronary ( artery ( bypass grafting ) ) ) ) ) ) . ) )

23efffa8-66c7-11e7-b6d4-f45c89b91419

entailment

Pseudomonal wound infections 8.

Patient has had prior infections

(ROOT (NP (NP (NP (JJ Pseudomonal) (NN wound) (NNS infections)) (NP (CD 8))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (VP (VBN had) (NP (JJ prior) (NNS infections))))))

( ( ( Pseudomonal ( wound infections ) ) 8 ) . )

( Patient ( has ( had ( prior infections ) ) ) )

23f00110-66c7-11e7-8edc-f45c89b91419

contradiction

Pseudomonal wound infections 8.

Patient has no PMH

(ROOT (NP (NP (NP (JJ Pseudomonal) (NN wound) (NNS infections)) (NP (CD 8))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (DT no) (NN PMH)))))

( ( ( Pseudomonal ( wound infections ) ) 8 ) . )

( Patient ( has ( no PMH ) ) )

23f0026e-66c7-11e7-884f-f45c89b91419

neutral

Pseudomonal wound infections 8.

Patient has a pressure ulcer

(ROOT (NP (NP (NP (JJ Pseudomonal) (NN wound) (NNS infections)) (NP (CD 8))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (DT a) (NN pressure) (NN ulcer)))))

( ( ( Pseudomonal ( wound infections ) ) 8 ) . )

( Patient ( has ( a ( pressure ulcer ) ) ) )

23f003f4-66c7-11e7-a352-f45c89b91419

entailment

Minimal vaginal bleeding.

The patient has an problem causing bleeding which is arising from her uterus or vagina.

(ROOT (NP (NP (JJ Minimal) (JJ vaginal) (NN bleeding)) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NP (DT an) (NN problem)) (VP (VBG causing) (NP (NP (NN bleeding)) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBG arising) (PP (IN from) (NP (NP (PRP$ her) (NN uterus)) (CC or) (NP (NN vagina)))))))))))) (. .)))

( ( Minimal ( vaginal bleeding ) ) . )

( ( The patient ) ( ( has ( ( an problem ) ( causing ( bleeding ( which ( is ( arising ( from ( ( ( her uterus ) or ) vagina ) ) ) ) ) ) ) ) ) . ) )